[
    {
        "pmid": "40814480",
        "title": "Importance of hospital-specific antibiotic policy for ensuring maternal quality of care in India: A narrative review.",
        "abstract": "Maternal health pivotal India infection significantly drive maternal morbidity mortality antibiotic essential preventing sepsis neonatal Group B Streptococcus surgical site infection SSI misusefueled empirical prescribing selfmedication overthecounter accesshas escalated antimicrobial resistance AMR challenge compounded Indias high maternal mortality uneven healthcare resources cultural practices Tailored hospitalspecific antibiotic policies grounded local epidemiology resistance patterns resources critical optimizing use enhancing care quality narrative review synthesized National ICMR NCDC International WHO ACOG guidelines local resistance data antibiograms epidemiological studies stewardship intervention related maternal infections Key source included AWaRe antibiotic classification local antibiograms Antibiotics classified first second thirdline treatment various obstetric condition treatment based patient demographics resources resistance patterns ongoing policy evaluation adapted hospitalspecific needs Recommendations adapted local resistance patterns resource availability patient demographics Excessive antibiotic use exacerbates AMR adverse outcomes hospitalspecific policy prioritizing narrowspectrum agents guided local antibiograms shown less complications Incorporating stewardship measure eg prophylaxis criteria formulary restrictions audits education improved guideline adherence curbed broad spectrum use bolstered neonatal safety Implementing hospitalspecific antibiotic policy effectively reduces infection rate improves maternalneonatal outcome standardized regimen prioritizing narrowspectrum antibiotic utilizing local antibiograms Key stewardship strategy included defined prophylaxis protocols formulary restrictions ongoing education contributing enhanced maternal neonatal safety Hospitalspecific antibiotic policy provide evidencebased framework optimizing antibiotic use obstetrics aligning national international guideline local epidemiological resistance data tailored policy strengthen antimicrobial stewardship clinical decisionmaking mitigate AMR improve maternal neonatal outcomes Implementing framework Indias diverse healthcare landscape vital safeguarding treatment efficacy improving outcome amid rising resistance effective maternal healthcare delivery India",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814480/",
        "source_type": "Global"
    },
    {
        "pmid": "40801958",
        "title": "Hidden risks of biofilm-forming and multidrug-resistant Gram-negative bacteria in water vending machines.",
        "abstract": "Water vending machine widely utilised various locations including workplaces university urban area due convenience accessibility However microbial quality water dispensed machines particularly residential colleges thoroughly studied study aim analyse physicochemical microbiological quality drinking water collected water vending machine located 14 residential college around Universiti Malaya Kuala Lumpur study revealed drinking water sample met acceptable limit pH TDS electrical conductivity However dissolved oxygen free chlorine level slightly acceptable range faecal contamination detected drinking water samples indicated absence enterococci coliform bacteria including faecal coliforms Nevertheless Gramnegative noncoliform bacteria identified water sample 11 residential colleges identified bacteria included Pseudomonas spp Acinetobacter spp Bosea sp Stenotrophomonas sp Achromobacter sp Roseatels sp Cupriavidus sp Using CLSI guideline standard antibiotic sensitivity test showed bacterial isolates resistant penicillin G 100 susceptible ofloxacin  80 Notably Pseudomonas spp Acinetobacter spp Stenotrophomonas sp Achromobacter sp Cupriavidus sp identified multidrugresistant bacteria showing resistance three category antimicrobial agent tested study biofilm assay confirmed Bosea sp Roseateles sp Acinetobacter sp possess biofilm formation capacity Overall study highlight water vending machine generally meet physicochemical standard free faecal contamination multidrugresistant Gramnegative bacteria still prevalent Although bacteria may pose immediate health risk upon consumption presence pose longterm risk due biofilm accumulation resistance gene transfer poor maintenance underscore need proper maintenance measure water vending machines including regular cleaning effective disinfection ensure microbial safety drinking water",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801958/",
        "source_type": "Global"
    },
    {
        "pmid": "40799958",
        "title": "A study protocol for the assessment of antibiotic use and bacterial antimicrobial resistance among children under five years of age: implications for a resource-limited setting.",
        "abstract": "irrational use antibiotic treat infection child crucial contributing factor bacterial antimicrobial resistance AMR economic health consequences morbidity mortality study aim evaluate antibiotic use AMR child five year age Sierra Leone study conducted three hospitals Ola Children Kenema Government Magburaka Government Hospitals Sierra Leone among healthcare professional patients mixedmethod qualitative quantitative approach used evaluate paediatric health professionals knowledge perceptions antibiotic prescription practices Additionally two crosssectional substudies assess inpatient outpatient trend antibiotic use consumption children crosssectional observational substudy investigate bacterial profile AMR among child bloodstream infections anatomical therapeutic chemical ATC World Health Organisation Access Watch Reserve WHO AWaRe classifications day therapy per 1000 patient day DOT1000PDs day therapy per 100 bed day DOT100BDs used determine use consumption DOT1000PDs DOT100BDs compared defined daily dose1000 patient day DDD1000PDs defined daily dose100 bed day DDD100BDs respectively pretested interview guide intervieweradministered questionnaire data collection tool adapted previous study employed data collection sample size determined appropriate sampling method used Data analysed thematically using NVivo 15 descriptive inferential statistic using R software result study inform policymakers healthcare professional developing andor implementing policies guidelines educational initiative promote antibiotic stewardship among child Sierra Leone",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799958/",
        "source_type": "Global"
    },
    {
        "pmid": "40780552",
        "title": "Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections.",
        "abstract": "Antimicrobial resistance increase risk misaligned initial antibiotic treatment IAT susceptibility data typically delayed causal effect patient outcomes however unclear due reliance observational study methodological heterogeneity describe terminology definition IAT misalignment evaluate method used analyse association mortality hospital length stay LOS patient drugresistant bloodstream infection BSIs systematic review DATA SOURCES PubMed EMBASE Jan1990 Aug2024 STUDY ELIGIBILITY CRITERIA included study drugresistant BSIs caused ESKAPE pathogen Enterococcus faecium Staphylococcus aureus Klebsiella pneumoniae Acinetobacter baumannii Pseudomonas aeruginosa Enterobacter specie Enterobacterales Eligible study defined IAT misalignment assessed effect mortalityLOS Patients drugresistant BSIs EXPOSURE misaligned IAT ASSESSMENT RISK BIAS Revised version JoannaBriggsInstitute tool METHODS DATA SYNTHESIS Qualitative synthesis RESULTS 3627 screened publications 187 study included predominantly cohort study n183 common terminology IAT misalignment inappropriate n139 743 followed inadequate n34 182 Definitions primarily considered invitro susceptibility prescribed antibiotics n184 984 9 additional criteria Impact inappropriate IAT mortality n186 mostly evaluated using logistic Cox regression including various confounder selection methods showing association 122186 study 656 Admissiontoinfection time infectiontotreatment time rarely considered Impact inappropriate IAT LOS shown 29 studies four study explicitly analysed postinfection LOS study scored low risk bias due residual confounding timedependent bias Wide variability IAT definition impact analysis observed high risk bias hindering data aggregation limiting understanding causal effect inappropriate IAT clinical outcomes Guidelines required improve study quality harmonise future research",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40780552/",
        "source_type": "Global"
    },
    {
        "pmid": "40778419",
        "title": "Antimicrobial susceptibility-guided treatment is superior to empiric therapy for Helicobacter pylori infection in children.",
        "abstract": "Helicobacter pylorus HP clinical guideline encourage obtaining gastric biopsy culture antimicrobial susceptibility guide therapy Susceptibilityguided treatment SGT reduces unnecessary exposure ineffective antibiotics minimizes adverse events promotes antimicrobial stewardship However realworld data effectiveness remains limited aim compare efficacy SGT empirical therapy ET Retrospective cohort study single pediatric tertiary care center Boston Childrens Hospital January2019 June2024 Firsttime H pylorihistological diagnosis subsequent treatment Data extracted demographic variables endoscopy indications endoscopic histological findings prior antimicrobial use treatment regimen eradication antimicrobial susceptibility compared eradication rate patient received ET versus received SGT among SGT recipients Two hundred eighteen study subject 95 ET 123 SGT included Mean age136 ± 48 years 509 male 596 White 381 Hispanic Endoscopic findings gastritis 927 duodenitis 115 gastric ulcererosion 50 duodenal ulcererosion 133 Eradication success significantly higher SGT group 894110121 compared ET group 702 6694 p  0001 Resistance rates clarithromycin 268 metronidazole 187 fluoroquinolones 98 amoxicillin 33 rifampin 89 tetracycline resistance Amoxicillin resistance strongly associated failure 273 vs 09 p  0002 dual clarithromycinmetronidazole resistance 364 vs 82 p  0018 univariate analysis amoxicillin resistance strongest association failure odds ratio OR 409 p  0001 followed dual clarithromycinmetronidazole resistance OR 641 p  0016 metronidazole resistance OR 426 p  0034 SGT resulted higher eradication rate ET Clarithromycin metronidazole resistance rate 15 Antibiotic resistance especially amoxicillin major driver eradication failure",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778419/",
        "source_type": "Global"
    },
    {
        "pmid": "40776712",
        "title": "Utilisation of antibiotics in a community pharmacy: A case from north-west, South Africa.",
        "abstract": "Antibiotic utilisation growing public health issue due antimicrobial resistance Community pharmacy key access point antibiotics thus evaluation dispensing record provide insight use describe utilisation antibiotic private community pharmacy study undertaken private pharmacy located North West province South Africa retrospective crosssectional study reviewed electronic dispensing record oral antibiotic January 2022 August 2024 categorising according World Health Organizations WHO Access Watch Reserve categories generic status diagnosis payment methods total 10 468 antibiotic dispensing record analysed Adults 1864 years accounted majority prescription 807 n  8446 Overall Access antibiotic mostly dispensed 565 n  5910 however azithromycin Watch antibiotic dispensed antibiotic n  1849 Notably 82 n 8584 prescription linked nonspecific International Classification Diseases 10th Revision codes Generic medicine constituted 926 n  9694 prescriptions Although patient 728 used medical aid cashpaying patient likely dispensed generic antibiotic Antibiotic prescribing largely aligned guidelines however high rate Access antibiotic dispensed highlight need targeted intervention improve prescribing practice guideline adherenceContribution case study indicates dispensing record contribute improved understanding local antibiotic usage pattern help combat antimicrobial resistance within community",
        "mesh_terms": [
            "Humans",
            "South Africa",
            "Anti-Bacterial Agents",
            "Adult",
            "Cross-Sectional Studies",
            "Retrospective Studies",
            "Middle Aged",
            "Adolescent",
            "Female",
            "Male",
            "Young Adult",
            "Pharmacies",
            "Community Pharmacy Services",
            "Drugs, Generic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776712/",
        "source_type": "Global"
    },
    {
        "pmid": "40775818",
        "title": "A Preliminary Result: Is Implementing WHO SMART Guidelines for AMR and AMU/C Surveillance in Indonesia Feasible?",
        "abstract": "Antimicrobial resistance AMR significant global health threat causing 10 million death annually Effective control antimicrobial use essential AMR surveillance Antimicrobial Use Consumption AMUC data playing crucial role Monitoring facilitated electronic prescription Electronic Medical Records EMR necessitating robust data exchange mechanism linked national dashboard Indonesias Satu Sehat policy standardizes data exchange across healthcare facilities promote adoption playbook developed detailing data exchange protocol various health programs including AMR AMUC paper aim explain development process AMR AMUC playbook desk reviews field observations focus group discussions focusing interoperable variable aligned FHIRHL7 standard health terminology like SNOMED CT LOINC ICD 10 playbook emphasizes limited set variable related electronic prescription culture testing offering pathway alignment SMART guidelines primarily addressing technical aspect data collection",
        "mesh_terms": [
            "Indonesia",
            "Humans",
            "Electronic Health Records",
            "World Health Organization",
            "Practice Guidelines as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775818/",
        "source_type": "Global"
    },
    {
        "pmid": "40765589",
        "title": "Antibiotic Prophylaxis in Orthopaedic Surgery: A Review and Institutional Experience.",
        "abstract": "Surgical site infection SSIs significant complication orthopaedic surgery Effective use antimicrobial prophylaxis critical reducing incidence without promoting resistance review current evidence antibiotic prophylaxis orthopaedic surgery analyse data institution effectiveness current prophylaxis protocols carried literature review retrospective analysis 1000 orthopaedic surgery done twoyear period timing duration antibiotic prophylaxis association postoperative SSI rate evaluated standard compared current antibiotic prophylaxis guideline trust policy institutional data demonstrated statistically significant difference SSI rate patient received 24hour versus received extended antibiotic prophylaxis Recent literature consistently support timely administration preoperative antibiotic discourages prolonged use beyond 24 hours line trust policy Preoperative administration single dose antibiotic maximum two dos remains effective preventing SSIs Extending prophylaxis beyond 24 hour offer additional benefit may promote antimicrobial resistance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765589/",
        "source_type": "Global"
    },
    {
        "pmid": "40765002",
        "title": "Neisseria Meningitidis Carriage Among Hajj and Umrah Pilgrims: A Systematic Review and Meta-Analysis.",
        "abstract": "Meningococcal meningitis MM caused bacterium Neisseria meningitidis represents considerable public health concern Hajj Umrah pilgrimages mass gathering close quarter associated event create environment enhances transmission potentially lifethreatening infection Despite mandatory vaccination policies concern persist regarding carriage rate potential outbreaks heightened several factors systematic review singlearm metaanalysis aimed evaluate carriage Neisseria meningitidis NM vaccination status among pilgrims systematic review metaanalysis conducted according PRISMA guidelines focusing Muslim pilgrim nationality participated mass gathering Hajj Umrah Makkah Saudi Arabia performed comprehensive search four electronic database PubMed Scopus Web Science Cochrane Central Register Controlled Trials inception April 2024 Eligible study reported N meningitidis carriage prevalence serogroups vaccination status among Hajj Umrah pilgrims primary outcome measured overall carriage prevalence Neisseria meningitidis determined time assessment Data synthesized using randomeffects models 417 study initially screened 21 study 23552 participants included systematic review metaanalysis consisted nine studies carriage prevalence NM Hajj 16 increasing 34 Hajj Prior Hajj estimate serogroup W recorded 0003 95 CI 0001 0006 0068 95 CI 014 015 respectively Following Hajj estimate shifted 0001 95 CI 0000 0002 serogroup 0072 95 CI 0037 0108 serogroup W Vaccination status varied gap among domestic pilgrims along presence ciprofloxacin resistance certain strains Saudi Arabias commendable sustained commitment proactive prevention strategy Hajj Umrah reduced Neisseria meningitis cases Nonetheless carriage variability rising antimicrobial resistance Neisseria meningitidis highlight need enhanced surveillance alternative prophylaxis strategy highrisk populations finding study remain inconclusive due significant heterogeneity underscore need comprehensive wellstructured primary study gather strong evidence",
        "mesh_terms": [
            "Humans",
            "Neisseria meningitidis",
            "Saudi Arabia",
            "Islam",
            "Meningitis, Meningococcal",
            "Carrier State",
            "Mass Gatherings",
            "Meningococcal Vaccines",
            "Prevalence",
            "Meningococcal Infections",
            "Crowding"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765002/",
        "source_type": "Global"
    },
    {
        "pmid": "40764898",
        "title": "Interplay between C-reactive protein responses and antibiotic prescribing in people with suspected infection.",
        "abstract": "Serial measurement Creactive protein CRP often taken hospital assess recovery infection utility remains debated Previous studies including development CRP centile reference chart suspected bloodstream infection BSI suggest variability CRP response across infection types investigated association serial CRP percentile changes antibiotic prescribing patterns patient outcome large cohort suspected infection acknowledging CRP one multiple factor clinical decisionmaking analysed 51544 suspected infection episode defined blood culture collection 36578 patient Oxfordshire UK 20162021 Episodes categorised blood culture results Grampositive Gramnegative polymicrobial contaminants culturenegative having previously shown 51 culturenegatives CRP response indistinguishable culturepositives spectrum antibiotic prescription change time tracked Multinomial logistic regression adjusted clinical covariates assessed association CRP percentile change subsequent prescribing decisions Linear mixed model evaluated CRP trajectory postprescribing logistic regression association early CRP change days 14 530day mortality Broadspectrum antibiotic predominantly used within first three day blood culture collection followed notable shift narrowspectrum antibiotic Grampositive infections slower deescalation Gramnegative polymicrobial infections CRP percentile change modestly associated subsequent antibiotic adjustments particular suboptimal recovery indicated increase CRP centiles associated higher rate antibiotic escalation 165 vs 107 expected recovery and conversely faster expected recovery CRP associated deescalation 236 vs 172 However 618 decision unchanged despite CRP trends relationship various prescribing decision subsequent CRP percentile change complex challenging estimate likely due testing bias CRP percentile change 4 day post blood culture collection strongly associated 530day mortality highlighting potential utility prognostic indicator CRP monitoring inform antibiotic stewardship association prescribing decision probably modest underscoring need integrate range clinical factor optimise infection management",
        "mesh_terms": [
            "Humans",
            "C-Reactive Protein",
            "Anti-Bacterial Agents",
            "Female",
            "Male",
            "Middle Aged",
            "Aged",
            "Adult",
            "Aged, 80 and over",
            "Practice Patterns, Physicians'",
            "United Kingdom",
            "Bacteremia",
            "Drug Prescriptions"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764898/",
        "source_type": "Global"
    },
    {
        "pmid": "40759719",
        "title": "Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers.",
        "abstract": "recent increase Latin American asylum seeker Spain accompanied rise HIV diagnoses However clinical profile particularly regarding antiretroviral resistance poorly characterized aimed assess prevalence resistanceassociated mutation impact treatment management vulnerable population conducted prospective cohort study 20222023 sixmonth followup enrolling Latin American asylum seeker living HIV attending first HIV consultation Spain Individuals viral load  1000 copiesmL regardless prior ART exposure underwent genotypic resistance testing Mutations identified using Surveillance Drug Resistance Mutations SDRM list resistance interpreted via Stanford HIV Drug Resistance Database algorithm 653 participants 153 met inclusion criteria 141 216 valid resistance results Overall 227 harbored SDRMs NNRTIs NRTIs PIs 150 ARTnaïve vs 328 ARTexperienced NNRTI mutation frequent 213 particularly ARTexperienced individual 311 NRTI mutation present 71 overall 131 ARTexperienced common mutation K103NS 191 P225H 50 M184V 43 Among ARTexperienced individuals resistance efavirenz nevirapine rilpivirine 311 327 197 respectively 114 showed lamivudine resistance Notably 823 ARTexperienced participant reported barrier healthcare access 90 rate treatment discontinuation cohort Latin American asylum seekers resistance NNRTIs alarmingly high especially among prior ART exposure interrupted treatment finding underscore need optimized treatment strategy improved healthcare access migrant population HIV",
        "mesh_terms": [
            "Humans",
            "HIV Infections",
            "Female",
            "Refugees",
            "Male",
            "Drug Resistance, Viral",
            "Adult",
            "Prevalence",
            "Latin America",
            "Prospective Studies",
            "Anti-HIV Agents",
            "Spain",
            "Mutation",
            "HIV-1",
            "Middle Aged",
            "Viral Load"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40759719/",
        "source_type": "Global"
    },
    {
        "pmid": "40755520",
        "title": "Implementation of Piperacillin-Tazobactam Continuous Infusions for Critically Ill Patients: A Single-Centre Retrospective Chart Review.",
        "abstract": "critically ill patients pharmacokinetic variability lead inadequate antimicrobial concentrations Antimicrobial resistance βlactam antibiotic increasing among nonfermenting gramnegative bacillus NFGNB Current guideline recommend optimizing βlactam pharmacokineticspharmacodynamics prolonged infusion antibiotics 2019 protocol continuous infusion piperacillintazobactam PT implemented 2 intensive care unit ICUs quality improvement initiative primary objective describe evaluate implementation practice change continuous infusion PT secondary objective describe ICU mortality length stay LOS identify safety incident related protocol determine prevalence NFGNB associated minimum inhibitory concentration PT singlecentre retrospective study involved convenience sample 200 patient received 2 dos PT ICU admission October 2020 October 2022 Data drug administration characteristic hospital stay patient outcome collected patients digital record Critical Care Database study institution Eight criterion successful implementation protocol established implementation deemed successful least 6 criterion met Implementation continuousinfusion protocol successful 156 780 200 ICU patients 41 205 patient died ICU admission median LOS ICU 49 interquartile range 24107 days safety incident identified prevalence NFGNB 31 ICU patient 2year study period Implementation continuousinfusion protocol successful patients Areas improvement include editing order set providing interprofessional education enhancing interprofessional collaboration",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755520/",
        "source_type": "Global"
    },
    {
        "pmid": "40749449",
        "title": "Antimicrobial prophylaxis in dogs undergoing catheter-based cardiac interventions and pacemaker implantation - A survey.",
        "abstract": "Guidelines prophylactic antimicrobial use catheterbased cardiac intervention pacemaker implementation dog exist Optimizing antimicrobial use rationalizing indication duration administration essential evergrowing threat antimicrobial resistance aim study reveal current habit prophylactic antimicrobial use among veterinarian perform transvascular cardiac intervention dogs digital survey offered via mailing list international veterinary cardiologyinterest group 141 respondent reported large variation protocol eg 47 different prophylaxis protocol pacemaker implantation Protocols differed administration yesno drug route duration administration only intravenous intravenous followed oral antimicrobials median duration antimicrobial course 7 day range 021 days Antimicrobial prophylaxis administered 89  141 respondent occlusion patent ductus arteriosus 76  139 respondent balloon valvuloplasty pulmonary valve stenosis 93  56 respondent transpulmonary stenting 96  136 respondent transvenous pacemaker implantation existence institutional guideline reported 30  respondents although also showed substantial variation eg 27 guideline 40 institution pacemaker implantation Veterinarians use prophylactic antimicrobial often longer period cardiac intervention human counterparts Antibiotic prophylaxis show little consistency veterinarians appear supported evidence necessity warrant reevaluation use creation guideline describing rational use antimicrobial interventional cardiac procedures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40749449/",
        "source_type": "Global"
    },
    {
        "pmid": "40738042",
        "title": "Symptomatic Mycoplasma genitalium infections in men who have sex with men and trans women: Should we skip macrolides?",
        "abstract": "Mycoplasma genitalium emerging sexually transmitted infection STI increasing antimicrobial resistance particularly among men sex men MSM study aimed evaluate incidence clinical characteristics antibiotic resistance pattern M genitalium among symptomatic MSM transgender woman TGW attending specialized STI clinic Barcelona Spain retrospective observational study conducted January December 2024 Symptomatic MSM TGW patient diagnosed M genitalium nucleic acid amplification testing NAAT included Macrolide fluoroquinolone resistance mutation detected using realtime PCR assays Patients treated according European guidelines resistanceguided therapy Among 71 patient M genitalium infection 535  presented urethritis 423  proctitis Coinfection STIs detected 35  295  history recent STI Alarmingly 859  patient carried azithromycin resistanceassociated mutations 423  showed dual resistance azithromycin moxifloxacin test cure TOC performed 26 patient 366  231  626 remaining positive mainly due dual resistance remaining 45 patient lost followup relapse recorded six month CONCLUSIONS high prevalence macrolideresistant M genitalium among MSM underscore need alternative firstline therapeutic strategies particularly setting limited access resistance testing research required optimize treatment regimen evaluate costeffectiveness routine macrolide susceptibility testing highrisk populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40738042/",
        "source_type": "Global"
    },
    {
        "pmid": "40735169",
        "title": "Antibiotic Use in Livestock and Environmental Antibiotic Resistance: A Narrative Review.",
        "abstract": "Antimicrobial use animal husbandry common practice developing country response growing demand animalbased foods Veterinary antibiotic account antibiotic used worldwide review aim provide overview impact antibiotic usage livestock production environment consequence emergence spread antibiotic resistance global estimate antibiotic consumption animal range 63 000 106 000 ton annually commonly used antibiotic class include tetracyclines sulfonamides βlactams macrolides trimethoprim antibiotic used animal treatment fully metabolized within animals body instead excreted enter environment review also provides brief overview fate antibiotic residue behavior environment developing countries addition lack data antibiotic use trends limitation implementing scientific regulatory framework antibiotic use livestock reduce projected loss life associated antimicrobial resistant infections recommended lower antibiotic contamination environment implementing affordable critical action related antibiotic usage residual waste management Actions rational use antibiotic circumstances reducing environmental exposure antibiotics research environmental surveillance important tackle problem antibiotic resistance especially lowincome countries",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40735169/",
        "source_type": "Global"
    },
    {
        "pmid": "40728717",
        "title": "[Perioperative antibiotic prophylaxis-The new German S3 guideline].",
        "abstract": "Antimicrobial stewardship AMS relatively new movement Germany aim rationalize use antibiotics primary aim halt global rise bacterial resistance course also affect Germany Perioperative antibiotic prophylaxis important topic AMS December 2024 new S3 guideline perioperative prophylaxis published Association Scientific Medical Societies Germany AWMF also presented hereSurgical site infection SSI greatly increased Germany recent years prevented perioperative antibiotic prophylaxis Nevertheless AMS reasons antibiotic prescription perioperative prophylaxis judicious many study shown optimal time administering antibiotic 3060 min surgical incision interval ensures adequate antibiotic concentration skin subcutaneous tissue history penicillin allergy preoperatively questioned small proportion patient report penicillin allergy actually one however betalactams important substance perioperative prophylaxis alternative substance clindamycin less effective resistance rate greatly increased Multidrugresistant pathogen MRE given special consideration new guideline list surgical procedure MRE considered well recommended screening adjustment substance selection situation important point perspective infectious diseases however duration perioperative antibiotic prophylaxis specified also new guideline with exceptions single dose plus intraoperative redosing event long duration surgery high intraoperative blood lossThe new guideline excellently summarize existing data based provide clear recommendations thus support AMS effort area exemplary manner",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40728717/",
        "source_type": "Global"
    },
    {
        "pmid": "40724599",
        "title": "<i>Mycobacterium Ulcerans</i> Ulcer: Current Trends in Antimicrobial Management and Reconstructive Surgical Strategies.",
        "abstract": "bBackgroundb iMycobacterium ulceransi cause Buruli ulcer BU necrotizing skin disease endemic 30 countries toxin mycolactone drive tissue destruction infection transmitted via environmental reservoir vectors Disease pattern vary globally improved understanding pathogenesis may enhance current antimicrobial surgical treatments bMethodsb comprehensive literature search 1901 2025 conducted across major database explore antimicrobial reconstructive surgical strategy iMycobacterium ulceransi Search term included BU key antibiotics surgical interventions Relevant Englishlanguage study treatment outcome reviewed summarize evolving management trend emerging therapeutic approaches bResults Discussionb review highlight importance early diagnosis timely antimicrobial therapy preventing disease progression limb loss review WHOrecommended antibiotic regimen discusses theoretical risk drug resistance although clinical resistance remains rare unreported Australia Surgical intervention select case crucial timing significant factor functional outcomes review also cover pediatricspecific challenges including growth preservation psychosocial support young patients Reconstructive option focus limb salvage staged reconstructions multidisciplinary care essential optimal outcomes paper advocate RCTs refine treatment protocols surgical guidelines explore emerging antibiotic therapy telacebec bConclusionsb BU remains global health challenge requiring early diagnosis timely antimicrobial therapy surgery selected cases Future research refine treatment reduce longterm impacts",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40724599/",
        "source_type": "Global"
    },
    {
        "pmid": "40723979",
        "title": "Antibiotic Prescription in Dentistry: Trends, Patient Demographics, and Drug Preferences in Germany.",
        "abstract": "bBackground objectivesb ABs widely used dental practice treatment odontogenic infection systemic prophylaxis highrisk patients However AB overuse contributes antimicrobial resistance AMR major global concern study examined dental AB prescribing trend Germany 2024 focusing share overall AB prescriptions patient demographics commonly used agents bMethodsb retrospective crosssectional study used data IQVIA Longitudinal Prescription Database LRx covering approximately 80 prescription reimbursed statutory health insurance fund Germany Patients least one AB prescription ATC code J01 issued dentist 2024 analyzed Descriptive statistic covered age sex prescribed substances bResultsb 2024 German dentist prescribed ABs 2325500 patients accounting 139 patient database received AB prescriptions Dentists secondlargest group AB prescribers surpassed general physicians Amoxicillin 542 frequently prescribed followed amoxicillin clavulanic acid 245 clindamycin 210 Dental patient receiving AB prescription older mean age 498 years general antibiotic patient population 447 years Interestingly dental AB prescription increased COVID19 pandemic contrast sharp overall decline AB prescriptions 2015 2019 proportion dental antibiotic prescription showed moderate upward tendency followed marked increase COVID19 pandemic subsequent decline contrast number patient receiving antibiotic prescription medical discipline decreased period One particularly notable finding extended use clindamycin reserve AB known side effect resistance risks dentistry bConclusionsb Dentists responsible significant share AB prescription Germany rise dental AB prescriptions particularly frequent prescription clindamycin underscore need intervention updated clinical guideline awareness campaign concerning ABrelated risk mitigation directed dentists could focus microbial culture sensitivity testing patient adherence education control targeted AB interventions Emphasizing preventive alternative antiinfective treatment strategy dentistry may also help contain AMR",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40723979/",
        "source_type": "Global"
    },
    {
        "pmid": "40716812",
        "title": "Current Challenges in Gonorrhea Management: A Focus on Diagnosis, Treatment, and Antimicrobial Resistance.",
        "abstract": "Gonorrhea caused Neisseria gonorrhoeae remains second common bacterial sexually transmitted infection United States approximately 157 million new infection annually growing challenge antimicrobial resistance AMR N gonorrhoeae led critical screening treatment guideline advancements study provides comprehensive review gonorrheas epidemiology pathophysiology clinical manifestations study also highlight role expedited partner therapy need enhanced patient education prevent reinfection discussion emphasizes importance ongoing surveillance updated clinical practices health education combat rising rate gonorrhea spread AMR",
        "mesh_terms": [
            "Humans",
            "Gonorrhea",
            "Anti-Bacterial Agents",
            "Neisseria gonorrhoeae",
            "United States",
            "Drug Resistance, Bacterial",
            "Female",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40716812/",
        "source_type": "Global"
    },
    {
        "pmid": "40718432",
        "title": "National antibiotic consumption for human use in Chad (2017-2021): a descriptive cross-sectional study.",
        "abstract": "Antibiotic resistance ABR commonly used antibiotic significant subSaharan Africa SSA SSA Chad one highest antimicrobial resistance AMR rates link ABR antibiotic consumption ABC wellestablished However ABCrelated study conducted Chad recently purpose study examine trajectory ABC Chad 2017 2021 using World Health Organizations WHO Access Watch Reserve AWaRe antibiotic classification descriptive retrospective study conducted NDjamena using antibiotic import distribution data collected General Directorate Pharmacy four wholesale distributor medicines defined daily dos DDDs mean relative change MRC used compute results Results presented term table graphs result compared WHOs guideline ABC use via AWaRe categorization 2017 2021 average ABC 25 dos per inhabitant per year observed peaking 2020 53 dos per inhabitant term DDD ten commonly consumed antibiotic time descending order amoxicillin ampicillin sulfamethoxazoletrimethoprim doxycycline ciprofloxacin phenoxymethylpenicillin erythromycin ceftriaxone azithromycin gentamicin However MRC analysis detected increase benzathine benzyl penicillin benzylpenicillin ampicillin amoxicillinclavulanic acid flucloxacillin ceftriaxone cefixime cefpodoxime cefalexin cotrimoxazole ciprofloxacin levofloxacin norfloxacin ofloxacin azithromycin Controversially amoxicillin cefotaxime doxycycline erythromycin moxifloxacin lower MRC 2017 2021 Although 90 ABC Access group Watch group increased time finding indicated significant ABC Chadian population 2017 2021 may elucidate countrys elevated ABR average 90 ABC categorized Access group although utilization Watch group increased time requires prompt implementation monitoring system ABC tier Chad",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718432/",
        "source_type": "Global"
    },
    {
        "pmid": "40714362",
        "title": "Short CIAFU recommendations on the screening and management of asymptomatic bacteriuria in immunocompromised patients.",
        "abstract": "Immunosuppression refers functional quantitative reduction immune defenses resulting diminished ability combat microbial pathogens Immunocompromised patient increased risk severe infections associated elevated morbidity mortality routine clinical practice urine culture often performed systematically patient considered risk infection regardless urinary symptoms aim detecting subsequently treating potential asymptomatic bacteriuria study aimed assess clinical relevance screening potentially treating asymptomatic bacteriuria immunocompromised individuals comprehensive literature search conducted using PubMed Medline without restriction language year publication complemented exploration scientific grey literature including expert report guideline professional societies Studies selected using following keywords antibiotic treatment urinary tract infection asymptomatic bacteriuria bacteriuria pyelonephritis cystitis immunodeficiency diabetes renal transplant neurogenic bladder cirrhosis pregnancy antimicrobial resistance abstract fulltext article reviewed synthesis finding subsequently evaluated member CIAFU expert committee formulated consensual recommendation possible Across reviewed literature clear benefit identified screening treating asymptomatic bacteriuria immunocompromised patients recommended screen treat asymptomatic bacteriuria immunocompromised patients except specific wellestablished scenarios Treating asymptomatic bacteriuria reduce infection risk rather increase likelihood adverse effect contributes development antimicrobial resistance associated morbidity mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714362/",
        "source_type": "Global"
    },
    {
        "pmid": "40707889",
        "title": "Epidemiological and molecular investigation of a Salmonella Agona-associated foodborne outbreak in Taiyuan, Shanxi Province, China, 2022.",
        "abstract": "July 23 24 2022 Qingxu Peoples Hospital Taiyuan reported increase acute gastroenteritis case among individual dined togetherAn investigation initiated identify factor associated acute intestinal infection prevent illness isolate cultivate identify pathogens collected sample patients food environment isolated strain underwent multiple tests including antimicrobial susceptibility testing pulsedfield gel electrophoresis PFGE wholegenome sequencing WGS Based WGS data analysis conducted including serotype prediction resistance gene prediction multilocus sequence typing MLST core genome multilocus sequence typing cgMLST single nucleotide polymorphism SNP analysis phylogenetic analysis total 11 sample collected Patient 1s residence supermarket included 2 sample leftover food family gathering 4 sample supermarket environment 5 stool sample 5 patients Among these two strain Salmonella isolated food three strain isolated patients stools five strain Salmonella identified Salmonella Agona S Agona susceptible 15 antibiotic tested PFGE banding pattern identical among strains Bioinformatics analysis revealed isolated strain S Agona sequence type ST13 cgMLST type cgST164980 carried resistance gene aac6laa fosA7 SNP disparity ranged 0 2 phylogenetic tree five strain S Agona isolated clustered closely together investigation food poisoning outbreak caused S Agona employed two key molecular techniques PulsedField Gel Electrophoresis PFGE Whole Genome Sequencing WGS PFGE provided initial highresolution DNA fingerprinting identify bacterial strain establish clonal relatedness offering preliminary crucial insight understanding microbial cause epidemic Subsequently WGS delivered comprehensive genetic information unparalleled precision confirming pathogen S Agona revealing genomic characteristics integration PFGE WGS result provided strong evidence proving epidemic related S Agona comprehensive approach confirmed etiology food poisoning event also highlighted power molecular genomic tool modern epidemiological investigations finding emphasize importance technique rapidly accurately identifying pathogens thereby enabling timely public health intervention reinforcing food safety measure prevent similar outbreak future",
        "mesh_terms": [
            "Humans",
            "China",
            "Disease Outbreaks",
            "Phylogeny",
            "Whole Genome Sequencing",
            "Multilocus Sequence Typing",
            "Male",
            "Salmonella",
            "Female",
            "Salmonella Food Poisoning",
            "Middle Aged",
            "Adult",
            "Electrophoresis, Gel, Pulsed-Field",
            "Anti-Bacterial Agents",
            "Polymorphism, Single Nucleotide",
            "Microbial Sensitivity Tests",
            "Salmonella Infections",
            "Food Microbiology",
            "Foodborne Diseases",
            "Feces",
            "Gastroenteritis",
            "Genome, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40707889/",
        "source_type": "Global"
    },
    {
        "pmid": "40691807",
        "title": "Mass drug administration trials of azithromycin: an analysis to inform future research and guidelines.",
        "abstract": "2020 World Health Organization published guideline use mass drug administration MDA broadspectrum antibiotic azithromycin reduce childhood mortality MDAazithromycin reduce mortality considered expansion setting populations care must taken maximize benefit reduce risk eg antimicrobial resistance AMR intervention Completed ongoing MDAazithromycin clusterrandomized clinical trial provide evidence extent benefit risk accrue identify practice monitor effect address evidence gap future trials examined azithromycin clinical trial registered ClinicalTrialsgov International Clinical Trials Registry Platform registry inception December 31 2023 included trial azithromycin administered prevention treatment disease condition explicitly diagnosed necessary participant inclusion treatment randomized geographic units identified evidence knowledge gaps trend highlight across five domains 1 targeting MDAazithromycin 2 clinical endpoints 3 co competing interventions 4 spillover effects 5 AMR monitoring 1589 screened studies 30 met inclusion criteria trial conducted 13 countries predominantly 2630 subSaharan Africa Nearly third 930 trial included mortality endpoints 29 included causespecific mortality endpoints New evidence suggests benefit widening target age group persistence mortality benefit setting competing interventions Published practice ensure geographic separation community different treatment arm reduce spillover effect customary found information AMR monitoring practice half trial 1630 these half 816 included phenotypic genotypic AMR testing half collected specimen assess nasopharyngeal gut microbiomes 916 tested nonmacrolide resistance 1116 longterm MDAazithromycin study determine additional country could benefit intervention accompany replace intervention extent AMR spillover occurs may prove valuable guideline revised",
        "mesh_terms": [
            "Azithromycin",
            "Humans",
            "Anti-Bacterial Agents",
            "Mass Drug Administration",
            "Randomized Controlled Trials as Topic",
            "Clinical Trials as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40691807/",
        "source_type": "Global"
    },
    {
        "pmid": "40690477",
        "title": "WHO-Point prevalence survey of antibiotic use in a Senegalese tertiary care hospital.",
        "abstract": "inappropriate use antibiotic human medicine one primary cause antimicrobial resistance objective study estimate prevalence antibiotic use Dakar Principal Hospital identify factor associated prescription broadspectrum antibiotics crosssectional study conducted according WHOpoint prevalence survey method included patient hospitalized acute care ward presented 800 day survey Data collected 9 29 December 2024 working days Multivariate logistic regression performed identify factor associated prescription broadspectrum antibiotics total 222 patients predominantly male sex ratio  126 included median age patient 2 year 45 year interquartile range 2964 years total 158 antibiotic prescription reported 101 included patients resulting prevalence 455 101222 prescription ratio 156 antibiotic per patient commonly prescribed antibiotic amoxicillinclavulanic acid n  36 162 followed ceftriaxone n  21 95 Community acquired infection common reason prescription n  86 544 98 prescription 62 compliance local guidelines Antibiotics watch group AWaRe classification used 55 patient 544 According multivariate analysis presence healthcareassociated infection associated use OR  121 95 CI 262937 antibiotic watch group significantly less commonly prescribed surgical prophylaxis OR  013 95 CI 002  063 prevalence antibiotic use high studied facility prescription belonging watch group result underscore need strengthen antimicrobial stewardship policies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40690477/",
        "source_type": "Global"
    },
    {
        "pmid": "40688175",
        "title": "The effect of antimicrobial stewardship interventions upon antimicrobial consumption and appropriateness in Vietnamese district hospitals: a cluster randomised trial.",
        "abstract": "Inappropriate antimicrobial use key driver antimicrobial resistance Antimicrobial stewardship AMS promotes judicious use antimicrobial address problem study evaluated effect AMS program antimicrobial prescribing practice district hospital Vietnam cluster randomised controlled trial conducted 16 district hospital northern southern Vietnam four months Hospitals randomly assigned intervention control groups Interventions included establishing AMS committee teams distributing antimicrobial guidelines training healthcare workers providing patient educational material conducting periodic audit feedback antimicrobial prescribing Coprimary outcome difference differences i total antimicrobial consumption ii inappropriate prescribing according standardised guidelines intervention intervention control groups Secondary outcome included antimicrobial cost allcause mortality intervention period control site also received AMS program Trial registry Australia New Zealand Clinical Trials Registry ANZCTR number 12622000715774 total 877 1220 antimicrobial prescription reviewed intervention hospitals 1277 1454 prescription control hospital baseline postintervention Inappropriate antimicrobial prescribing exceeded 60 hospital baseline intervention inappropriate prescribing intervention group reduced 63 95 CI 109 17 relative control group Total antimicrobial consumption differ groups antimicrobial cost reduced intervention group difference allcause mortality observed AMS intervention modestly reduced inappropriate antimicrobial prescribing district hospital Vietnam underscoring importance AMS resourcelimited settings Australian Department Foreign Affairs Trade",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40688175/",
        "source_type": "Global"
    },
    {
        "pmid": "40667421",
        "title": "The challenge of multidrug resistance in hospitalized pediatric patients with urinary tract infections.",
        "abstract": "choice empirical treatment pediatric urinary tract infection UTIs increasingly complicated emergence antibiotic resistance growing prevalence multidrugresistant organism MDROs aim study assess resistance pattern isolated uropathogens among child adolescent hospitalized UTIs Lebanon determine risk factor associated MDROrelated UTIs 10year period retrospective chart review conducted two tertiary medical center Beirut Children adolescent less 18 year admitted January 1 2011 December 31 2021 following ICD10 codes urinary tract infection cystitis andor pyelonephritis  included case excluded urine culture polymicrobial meet definition UTI used Univariate multivariable logistic regression analysis performed identify risk factor MDRO infections Among 876 pediatric UTI case included 85 2 month age 741 females 645 644 iEscherichia colii 619 114 iKlebsiellai spp isolates met international MDR criteria period fluctuation proportion MDROs began steadily increase starting 2019 eventually surpassing 2011 percentage nearly 10 2021 679 ipi  0248 21 MDR iE colii 29 MDR iKlebsiellai spp resistant carbapenems However aminoglycoside resistance high ranging 283 486 Children aged ≥ 5 year nearly twice likely present MDR uropathogen compared  5 year age ipi  0001 history leukemia ipi  0010 AOR  4248 95 CI 141212778 antibiotic use preceding 30 day ipi  0012 AOR  2045 95 CI 11673582 found independent risk factor UTIs caused MDROs multivariable logistic regression study highlight increasing threat MDROs among pediatric UTIs Recent antibiotic use strongly associated MDRO infection highlighting urgent need effective antimicrobial stewardship reevaluation empiric treatment guidelines strict abidance infection control measures",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Urinary Tract Infections",
            "Retrospective Studies",
            "Child",
            "Adolescent",
            "Child, Preschool",
            "Drug Resistance, Multiple, Bacterial",
            "Infant",
            "Risk Factors",
            "Anti-Bacterial Agents",
            "Lebanon",
            "Hospitalization",
            "Microbial Sensitivity Tests",
            "Escherichia coli",
            "Tertiary Care Centers",
            "Prevalence",
            "Infant, Newborn",
            "Klebsiella"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40667421/",
        "source_type": "Global"
    },
    {
        "pmid": "40635010",
        "title": "The status of infection prevention and control structures in secondary and tertiary hospitals in Northwest China: findings from WHO Infection Prevention and Control Assessment Framework (IPCAF).",
        "abstract": "Healthcareassociated infection HAIs antimicrobial resistance AMR pose significant challenge healthcare institution worldwide Implementing effective infection prevention control IPC measure crucial reducing risk HAIs However limited research conducted current status IPC secondary tertiary hospital Shaanxi Province China study aim comprehensively quantitatively evaluate IPC practice hospital using IPC Assessment Framework IPCAF crosssectional study conducted Shaanxi Province China February April 2024 collaboration Provincial Center Nosocomial Infection Control Quality Improvement NICQI 10 regional NICQIs Using stratified multistage sampling approach secondary tertiary hospital selected Data collected via electronic questionnaire distributed WeChat groups ensure data quality pilot survey performed standardized training provided investigators total 171 hospital participated survey 108 secondary hospital 6316 63 tertiary hospital 3684 overall median IPCAF score 6425 interquartile range IQR 545710 secondary hospital scoring 600 IQR 50756825 tertiary hospital 705 IQR 6375755 indicating significant difference hospital grade P  005 According criteria 106 hospital 6199 achieved advanced IPC level Among core component CC scores CC5 Multimodal strategies CC7 Workload staffing bed occupancy lowest median score 75 CC8 Built environment material equipment IPC facility level CC2 IPC guidelines highest median score Secondary tertiary hospital Shaanxi Province demonstrated relatively high level IPC However resource allocation facility upgrade secondary hospital require enhancement identified strength area improvement accordance observed uppermiddle income countries particularly respect multimodal strategies",
        "mesh_terms": [
            "China",
            "Humans",
            "Cross-Sectional Studies",
            "Tertiary Care Centers",
            "Cross Infection",
            "Infection Control",
            "Surveys and Questionnaires",
            "World Health Organization",
            "Secondary Care Centers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40635010/",
        "source_type": "Global"
    },
    {
        "pmid": "40629385",
        "title": "Prevalence and antimicrobial resistance of Salmonella enterica isolated from cattle farms in Inner Mongolia.",
        "abstract": "Salmonella pose significant health threat human animal owing emergence antimicrobialresistant strains study incidence pattern salmonellosis multidrugresistant Salmonella strain Inner Mongolia Chinas milk beefproducing hotspot Farms Inner Mongolia China randomly selected rectal swab 600 milk sample 757 collected isolation identification Salmonella antimicrobial resistance assessed according CLSI NARMS guidelines Twentyone resistance gene seven class antibiotic selected detection using polymerase chain reaction PCR SalmonellaNMGS9 selected whole genome sequencing drug resistance gene prediction analysis Salmonella found 24 8571 28 largescale cattle farm Inner Mongolia China resulting 176 Salmonella strain 1357 sample with prevalence 388 158 strain tested susceptibility 19 antibiotics multidrugresistant MDR strain accounted 9051 143158 6 strain resistant sulfisoxazole Furthermore 40 30 strain sul3 sul1 genes strain sensitive polymixin B strain mcr1 gene Among 8 S enterica strain 559 14 gene identified βlactam gene blasubTEM1sub expressed MDR isolates floR tetB gene consistent PCR result predicted drug resistance gene SalmonellaNMGS9 strains study first determine prevalence antimicrobial resistance genetic characteristics Salmonella spp isolated largescale cattle farm Inner Mongolia China Monitoring prevalence resistance gene expression distribution Salmonella largescale cattle farm Inner Mongolia vital understanding extent trend foodborne pathogen resistance China",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "China",
            "Salmonella Infections, Animal",
            "Salmonella enterica",
            "Prevalence",
            "Cattle Diseases",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Drug Resistance, Multiple, Bacterial",
            "Drug Resistance, Bacterial",
            "Milk"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40629385/",
        "source_type": "Global"
    },
    {
        "pmid": "40624474",
        "title": "HIVGenoPipe: a nextflow pipeline for the detection of HIV-1 drug resistance using a real-time sample-specific reference sequence.",
        "abstract": "emergence HIV drug resistance challenge controlling acquired immunodeficiency syndrome AIDS pandemic caused human immunodeficiency virus1 HIV1 infection Detection drug resistance variant minor frequency help formulate successful antiretroviral therapy ART regimen people living HIV PLWH reduce emergence drug resistance Therefore pipeline accurately produce consensus nucleotide sequence identify drug resistance mutation DRMs defined frequency threshold helpful treatment PLWH analysis virus evolution control pandemic developed pipeline HIVGenoPipe determine HIV drug resistance variant within gagpol region userdefined frequency HIV1 sample sequenced using Illumina technology pipeline validated comparing result result generated widely used pipeline HyDRA limited pol region result generated Sanger sequencing technology using set 30 samples variant frequency used generate ambiguous consensus sequence HIVGenoPipe accurate pipeline samplespecific reference generated realtime novel hybrid strategy de novo referencebased assembly used frequency calculation leading accurate drug resistance call use clinicians addition since Nextflow used pipeline platform HIVGenoPipe inherently great portability scalability reproducibility component updated replaced independently required developed HIVGenoPipe detection HIV1 drug resistance construct accurate gagpol consensus sequences leading improved detection DRMs HIVGenoPipe open source freely available MIT license httpsgithubcomLHRIBioinformaticsHIVGenoPipe  current release v101 archived available httpsdoiorg httpsdoiorg105281zenodo15528502 ",
        "mesh_terms": [
            "HIV-1",
            "Drug Resistance, Viral",
            "Humans",
            "Mutation",
            "Software",
            "HIV Infections",
            "High-Throughput Nucleotide Sequencing",
            "Sequence Analysis, DNA"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40624474/",
        "source_type": "Global"
    },
    {
        "pmid": "40612163",
        "title": "Antibiotic Prescription Trends Among Pediatric Patients in Dessie Comprehensive Specialized Hospital, Ethiopia.",
        "abstract": "iIntroductioni Antibiotic overuse critical global health issue drive antibiotic resistance especially lowincome country like Ethiopia data prescribing practice scarce iObjectivei study assessed antimicrobial prescription pattern pediatric patient Dessie Comprehensive Specialized Hospital Northeast Ethiopia iMethodsi retrospective crosssectional analysis 171 pediatric inpatient prescription March April 2022 conducted using pediatric guideline Ethiopias Standard Treatment Guideline STG evaluation iResultsi Among 157 analyzed prescriptions patient 554 hospitalized 5 days Severe acute malnutrition 274 meningitis 14 leading cause admission Ceftriaxone 51 augmentin 19 frequently prescribed inappropriate use noted 102 cases Injectable antibiotic used 624 prescriptions iConclusioni Ceftriaxone primary antibiotic prescribed generally rational prescribing pattern However additional attention patient comorbidities rural background advised",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40612163/",
        "source_type": "Global"
    },
    {
        "pmid": "40601222",
        "title": "Rational Antibiotic Use in Office Practice.",
        "abstract": "Antimicrobial resistance AMR emerging global health threat Microbial resistance emerged almost simultaneously discovery penicillin kept pace almost every new antibiotic molecule increasing AMR declining initiative discovery newer antibiotic research pharmacologic industry humanity may entering postantibiotic era inability treat infection per global estimate AMR rank high third leading cause death India largest consumer antibiotic face huge burden AMR ICMR data reveals methicillin resistant Staphylococcus aureus MRSA prevalence half specimen among Gram negative organisms carbapenem resistance seen nearly 50 E coli klebsiella 2023The contributory factor AMR patient prescriber system environment related well rampant use antibiotic animal husbandry aquaculture biocides Government India making effort restrict AMR National Action Plan strategy enhancing knowledge AMR improving Antimicrobial Stewardship monitoring antibiotic use increasing coordination among stakeholder One Health initiative promote rational antibiotic choice prevent AMR categorised antibiotic per level need Access Watch Reserve AWaRe antibiotics Robust National guideline available treat infection encountered office practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40601222/",
        "source_type": "Global"
    },
    {
        "pmid": "40600150",
        "title": "Containment of a carbapenem-resistant <i>Klebsiella pneumoniae</i> in an intensive care unit during the COVID-19 pandemic.",
        "abstract": "nosocomial outbreak icarbapenemresistant Klebsiella pneumoniaei CRKP occurred 20bed Respiratory Intensive Care Unit RICU tertiary teaching hospital COVID19 pandemic December 2022February 2023 outbreak ultimately mitigated multimodal infection control intervention aligned multidrugresistant organism MDRO management guidelines Following index case identification 10 December 2022 multidisciplinary outbreak response team implemented comprehensive control measures Immediate geographic cohorting CRKPpositive patient dedicated staff Enhanced contact precaution including daily chlorhexidine bathing Tridaily environmental decontamination using sporicidal agents Mandatory hand hygiene audit realtime feedback Active surveillance weekly rectal swab RICU admissions Environmental monitoring encompassed 120 hightouch surface sampled weekly Among 42 laboratoryconfirmed CRKP cases 857 ini  36 identified clinical specimen 143 ini  6 via active surveillance Postoutbreak surveillance revealed two imported CRKP case detected admission screening threemonth followup period contained without secondary transmission increasing patient volume prolonged use personal protective equipment PPE influx new healthcare worker heightened risk CRKP transmission Effective administrative guidance nosocomial infections behavioral control active surveillance culture environmental cleanliness antimicrobial management essential prevent outbreak outbreak demonstrates viability containing CRKP transmission resourceconstrained pandemic setting through rigorous adherence contact precautions prospective CRE active surveillance cultures also need implement antimicrobial stewardship program order reduce occurrence microbial resistance",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Intensive Care Units",
            "Klebsiella pneumoniae",
            "Infection Control",
            "Cross Infection",
            "Klebsiella Infections",
            "Carbapenems",
            "Male",
            "Female",
            "Middle Aged",
            "SARS-CoV-2",
            "Carbapenem-Resistant Enterobacteriaceae",
            "Aged",
            "Disease Outbreaks",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40600150/",
        "source_type": "Global"
    },
    {
        "pmid": "40597784",
        "title": "Delayed culture conversion predicts poor outcomes for isoniazid mono-resistant TB in Uganda: a retrospective cross-sectional study from 2017- 2022.",
        "abstract": "Isoniazidresistant Rifampicinsusceptible Tuberculosis TB estimated occur 13 new case 17 previously treated cases Current guideline recommend treatment Rifampicin RFP ethambutol EMB E pyrazinamide PZA Z levofloxacin LFX Q 6 month patient isoniazid monoresistant TB HrTB effectiveness use regimen managing HrTB established need pay increased attention timely identification HrTB patient improve treatment success along reduction risk drug resistance development study performed determine treatment outcome associated factor among isoniazid monoresistant TB patient Uganda crosssectional study performed among newly diagnosed retreatment TB patient whose sputum sample referred National TB Reference Laboratory NTRLUganda March 2017 March 2022 Patient sample exhibiting Isoniazid monoresistance determined phenotypic drug resistance testing DST included study Samples data incompleteness whose treatment center could traced excluded study Selected sample tested mutation associated Isoniazid resistance using line probe Patient demographic data obtained National TB Reference Laboratory NTRL electronic data system request form additional data treatment regimen adverse effects treatment start date obtained treatment registers independent variable available age sex regimen used M tuberculosis mutation gene isoniazid specifically InhA KatG history TB HIV status reporting year assessed possible factor relationship HrTB treatment success total 85 isoniazid monoresistant isolates different patient analyzed study study participant belonged category newly diagnosed 3585 412 participant 3685 423 turned culture negative month one upon initiation treatment finding study show dominant Mycobacterium tuberculosis mutation occurred KatG MUT1 region nucleotide change S315T1 significant treatment outcome difference among different age group study compared unsuccessful Vs successful treatment median age 354 year 3586 years p  0078 However study found death among people aged 36 year 714 57 participants study revealed Isoniazid monoresistant TB significant factor associated delayed culture conversion beyond two 2 months emphasizes need prompt detection using routine pointofcare testing molecular diagnostic platform test Isoniazid Rifampicin resistance improve TB treatment outcome reduce failures applicable",
        "mesh_terms": [
            "Humans",
            "Uganda",
            "Isoniazid",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Antitubercular Agents",
            "Adult",
            "Mycobacterium tuberculosis",
            "Retrospective Studies",
            "Middle Aged",
            "Treatment Outcome",
            "Drug Resistance, Bacterial",
            "Microbial Sensitivity Tests",
            "Young Adult",
            "Rifampin",
            "Adolescent",
            "Pyrazinamide",
            "Sputum"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40597784/",
        "source_type": "Global"
    },
    {
        "pmid": "40597774",
        "title": "A prospective cluster randomized trial of an interventions bundle to reduce inappropriate antibiotic use for upper respiratory tract infections in the outpatient setting.",
        "abstract": "Antibiotic overuse increasing antimicrobial resistance global public health threats determined impact multicomponent intervention reducing inappropriate antibiotic use upper respiratory tract infection URTIs outpatient setting DESIGN Prospective clusterrandomized trial Bundled 4component intervention including extensive provider education decision support algorithm option deferred antibiotic prescription monthly feedback prescription patterns vs single randomly assigned intervention decision support algorithm Four Primary healthcare center Qatar study period August 2023 October 2024 Individuals diagnosis URTI prescribed antibiotics Reduction inappropriate antibiotic prescription URTIs intervention vs control group 11month followup period analyzed 20062 episodesofcare URTIs antibiotic prescription 9277 control 10785 intervention sites mixed effect logistic regression model accounting clustering effect intervention associated 29 reduction odds inappropriate antibiotic prescription  aOR 071 95 CI 066077 relative reduction 209 449 vs 355 p  0001 two groups relative drop inappropriate antibiotic prescription intervention 163 424 v 355 p  0001 intervention site p  0001 compared 22 459 449 p  04 control sites Seniormost physician younger population 1940 year old likely prescribe receive inappropriate antibiotic prescription multicomponent intervention significantly reduce inappropriate antibiotic prescription URTIs outpatient setting NCT06135376 Registration Date November 9 2023",
        "mesh_terms": [
            "Humans",
            "Respiratory Tract Infections",
            "Anti-Bacterial Agents",
            "Male",
            "Female",
            "Prospective Studies",
            "Inappropriate Prescribing",
            "Middle Aged",
            "Adult",
            "Outpatients",
            "Young Adult",
            "Qatar",
            "Aged",
            "Antimicrobial Stewardship",
            "Adolescent",
            "Child"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40597774/",
        "source_type": "Global"
    },
    {
        "pmid": "40597250",
        "title": "A systematic review on natural products with antimicrobial potential against WHO's priority pathogens.",
        "abstract": "Antimicrobial resistance AMR critical global issue bacteria increasingly resistant traditional antibiotics resulting treatment failure higher mortality rates Resistance defined microbiologically clinically arises genetic mutation acquired traits response growing threat World Health Organization WHO established priority list antibioticresistant bacteria 2016 guide research development new antimicrobial agents COVID19 pandemic exacerbated AMR underscoring urgent need new antibiotics Natural product continue valuable source antibacterial compound play significant role developing new antimicrobial treatments study employed systematic review methodology conducting comprehensive search across PUBMEDMEDLINE WEB SCIENCE SCOPUS databases adhering modified PRISMAScR reporting guidelines research librarian assisted developing search strategy search executed May 5 2024 without restriction publication dates Titles abstract screened using Rayyan Endnote Inclusion criterion focused original study examining antimicrobial effect natural product antibioticresistant pathogens including risk estimate 95 confidence intervals review identified significant effect natural product 12 family antibioticresistant bacteria reported World Health Organization WHO finding underscore potential natural compound therapeutic agent combating antimicrobial resistance total 4371 article published 2014 2024 initially identified 290 article selected detailed review based relevance study period included study clinical trials analysis indicated research dietary plant conducted country within Middle East South America Africa Among pathogen investigated Pseudomonas aeruginosa Escherichia coli Klebsiella pneumoniae Salmonella typhi Staphylococcus aureus emerged frequently studied due involvement wide range infectious diseases finding revealed alkaloids flavonoids phenols saponins tannins terpenoids principal class plantderived compound exhibiting antioxidant activity bacterial strains bioactive compound extracted using variety solvents including ethanol methanol aqueous solutions benzoate ethyl acetate nbutanol methanolic preparation obtained different plant part leaves bark flowers roots Notably flavonoid represented 248 antioxidant product derivative examined overall result underscore significant therapeutic potential regional medicinal plant combating pathogen resistant chemical drugs antioxidant cytotoxic property may enhance efficacy existing antibiotic class contribute reversing antimicrobial resistance Based finding review diverse effect therapeutic efficacy herbal compound managing antibiotic resistance extensively examined Consequently light demonstrated antimicrobial activity plantderived compounds investigation potential alternative agent counteract antibiotic resistance become increasingly essential",
        "mesh_terms": [
            "Biological Products",
            "Humans",
            "World Health Organization",
            "Anti-Bacterial Agents",
            "Drug Resistance, Bacterial",
            "Bacteria",
            "Anti-Infective Agents",
            "COVID-19"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40597250/",
        "source_type": "Global"
    },
    {
        "pmid": "40596923",
        "title": "Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development.",
        "abstract": "Drugresistant tuberculosis emerged major public health issue requires immediate attention NTS innovative method allows direct detection clinical sample without need culture could provide accurate reliable comprehensive information drug resistance collected clinical data retrospectively patient suspected drugresistant tuberculosis visited tuberculosis department Second Hospital Nanjing Jiangsu Province China December 2023 December 2024 diagnostic efficiency NTS different type drugresistant tuberculosis antimicrobial resistance calculated relationship resistance genes mutated amino acids mutation site demonstrated study total 107 patient drugresistant tuberculosis included comprising 43 case monodrug resistant tuberculosis 20 patient polydrug resistant tuberculosis 22 case multidrugresistant tuberculosis 21 case preextensively drugresistant tuberculosis 1 case extensively drugresistant tuberculosis accuracy NTS diagnosing drugresistant tuberculosis ranged 429 930 Except secondline injectable drugs NTS achieved sensitivity 70 antituberculosis drugs Serine identified frequently mutated amino acid rpoB gene 662 4974 katG gene 863 4451 Additionally frequently mutated amino acid embB gene rpsL gene gyrA gene methionine 947 4451 lysine 100 2828 aspartic acid 667 2030 respectively NTS could effectively precisely deliver comprehensive drug resistance results assisting medical professional create personalized treatment plans Besides would encourage development new antituberculosis drug broaden clinical treatment option drugresistant tuberculosis",
        "mesh_terms": [
            "Humans",
            "Tuberculosis, Multidrug-Resistant",
            "Mycobacterium tuberculosis",
            "Retrospective Studies",
            "Antitubercular Agents",
            "Female",
            "Male",
            "Adult",
            "Middle Aged",
            "Precision Medicine",
            "Mutation",
            "Nanopore Sequencing",
            "Drug Development",
            "Bacterial Proteins",
            "China",
            "Young Adult",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40596923/",
        "source_type": "Global"
    },
    {
        "pmid": "40594052",
        "title": "An exploratory mixed methods study on shared decision-making and antibiotic prescribing for pet cats and dogs in Singapore veterinary clinics.",
        "abstract": "Veterinarians primarily engage pet owner shared decisionmaking SDM enhance treatment outcome owner satisfaction specifically antibiotic stewardship study aim understand SDM occurs better involve pet owner appropriate antibiotic prescribing pets concurrent mixed method study anchoring survey data collected 1080 pet catdog owner March─December 2023 supplemented qualitative insight 19 veterinarian January─July 2022 Statistical thematic analysis performed received antibiotic pet last veterinary consultation N  415 227 engaged SDM veterinarian antibiotic prescribing Pet owner high degree control empowerment interact veterinary professional likely so Veterinarians capable engaging pet owner SDM exploring owners need feeding concern key Pet owner trusted veterinarians final antibiotic decision desired appropriate antibiotic prescription them alongside training advice best medicate pet antibiotics Proactive exploration pet owners need concerns providing pet owner necessary training advice enhance antibiotic stewardship pet cat dogs",
        "mesh_terms": [
            "Animals",
            "Cats",
            "Anti-Bacterial Agents",
            "Dogs",
            "Humans",
            "Veterinarians",
            "Pets",
            "Singapore",
            "Female",
            "Male",
            "Decision Making, Shared",
            "Antimicrobial Stewardship",
            "Surveys and Questionnaires",
            "Adult",
            "Middle Aged",
            "Drug Prescriptions",
            "Ownership"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40594052/",
        "source_type": "Global"
    },
    {
        "pmid": "40581330",
        "title": "Epidemiology of Neisseria gonorrhoeae in South-East Asia: Systematic review, meta-analyses, and meta-regressions.",
        "abstract": "epidemiology Neisseria gonorrhoeae NG infection SouthEast Asia remains inadequately understood study aimed systematically review analyze available evidence NG prevalence provide understanding epidemiology region highlighting prevalence patterns key population risk factor influencing transmission systematic review literature September 3 2024 conducted finding reported accordance PRISMA guidelines Randomeffects metaanalyses performed estimate pooled mean prevalence metaregression analysis conducted explore associations assess time trends identify source heterogeneity across studies review identified 474 relevant publications encompassing 885 overall 1136 stratified NG prevalence measures pooled mean prevalence urogenital infection 05 95 CI 0308 general populations 139 95 CI 119161 among female sex workers 168 95 CI 126215 among sexually transmitted infection clinic attendees 46 95 CI 2965 symptomatic women 385 95 CI 318453 symptomatic men Among men sex men transgender people male transgender sex workers pooled mean prevalence 09 95 CI 0415 urogenital infection 120 95 CI 88157 anorectal infection 71 95 CI 40109 oropharyngeal infection Multivariable metaregression analysis explained 55 variation prevalence revealing hierarchical pattern population type higher prevalence among men decline prevalence 2 per calendar year past four decades NG prevalence SouthEast Asia comparable global prevalence markedly high prevalence among key populations coupled Asias substantial burden gonococcal antimicrobial resistance underscore urgent need targeted intervention focused vulnerable groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40581330/",
        "source_type": "Global"
    },
    {
        "pmid": "40575279",
        "title": "ePOCT+ Rwanda: A Clinical Decision Support Algorithm For Managing Sick Children Below 15 Years of Age in Primary Healthcare Settings.",
        "abstract": "Primary health system resourceconstrained setting suffer human resource shortages low quality care diagnostic uncertainty resulting overreliance antibiotics increasing risk antimicrobial resistance Digital clinical decision support algorithm CDSAs help healthcare worker adhere clinical guideline improve prescribing practices manuscript present scope content ePOCT Rwanda electronic PointOfCare Tests  CDSA trialed primary health center Rusizi Nyamasheke district DYNAMIC project algorithm based IMCI guidelines expanded include broader range age between 1 day 14 years inclusive acute medical condition encountered primary care 57 diagnosis young infant  2 month 144 diagnosis child 2 month 14 years digital application used deploy ePOCT prompt user enter result medical history physical examination laboratory test propose diagnoses treatment managements addition routine pointofcare tests ePOCT utilizes haemoglobin Creactive protein tests well pulse oximetry targeted specific clinical conditions discus rationale behind content algorithm process aligning Rwandan paediatric guideline tailoring primary care setting",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40575279/",
        "source_type": "Global"
    },
    {
        "pmid": "40547272",
        "title": "New Paradigm for Battling Hospital-Acquired Infections in Developing Countries.",
        "abstract": "Healthcareassociated infection HAIs pose critical threat maternal child health lowresource settings Kano State Nigeria reporting 63 national HAI burden 85 diphtheria cases Despite global infection prevention control IPC advancements implementation gap persist study engaged 50 multidisciplinary stakeholder including Kano State CDC WHO UNICEF healthcare leaders community representative threeday participatory workshop codevelop contextspecific IPC framework Key outcome included standardized state IPC guidelines facilitylevel monitoring committees enhanced healthcare worker training postexposure prophylaxis PEP protocols dedicated isolation centers initiative reduced HAIs 42 ip  001i pilot facilities notable improvement pediatric maternal wards Barriers inconsistent PPE access reported 68 staff addressed localized solutions including community health worker engagement Aligned WHOs Strategic Goal Five SDG target quality care antimicrobial resistance AMR reduction model demonstrates stakeholderdriven IPC strategy mitigate outbreak highburden settings Findings advocate scalable participatory approach strengthen health systems directly impacting maternalchild survival AMR containment Nigeria similar regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40547272/",
        "source_type": "Global"
    },
    {
        "pmid": "40537577",
        "title": "Retrospective, single center evaluation of transperineal prostate biopsy omitting antibiotic prophylaxis and omitting periinterventional screening for bacteriuria.",
        "abstract": "Although pursuit effective safe early detection method prostate cancer led advancement noninvasive tools approximately one million prostate biopsy per year performed annually EU 11 use transperineal approach prostate biopsy increasing offer significantly reduced incidence postbiopsy sepsis complication compared transrectal biopsy therefore recommended approach European Association Urology guidelines However consensus standard care antibiotic prophylaxis transperineal biopsy case beginning established transrectal biopsies concern antibiotic stewardship antibiotic side effect labor material cost associated prophylaxis retrospective study analyzed 636 patient underwent transperineal prostate biopsy without use antibiotic prophylaxis January 2019 August 2020 primary endpoint rate postinterventional infectious complications secondary endpoint including rate general complication associated risk factors rate complication 19 7636 11 infectious complications 3 050 prostatitis 1 016 epididymitis 2 03 infection resulting hospitalization 1 016 urosepsis ICU care identified risk factor associated infectious complication postinterventional bleeding Notably cohort systematically screened bacteriuria biopsy patient usually categorized high risk postbiopsy complication excluded rate infectious complication sepsis lower reported transrectal biopsy antibiotic prophylaxis study support relative safety omitting antibiotic prophylaxis transperineal prostate biopsies showcasing minimal infectious complication rate finding contribute ongoing discourse antibiotic stewardship emphasizing need judicious use mitigate resistance avoid allergic side effect decrease labor material cost associated transperineal prostate biopsy",
        "mesh_terms": [
            "Retrospective Studies",
            "Bacteriuria",
            "Prostate",
            "Antibiotic Prophylaxis",
            "Biopsy",
            "Prostatitis",
            "Epididymitis",
            "Cross Infection",
            "Sepsis",
            "Antimicrobial Stewardship",
            "Prostatic Neoplasms",
            "Humans",
            "Male",
            "Middle Aged",
            "Aged",
            "Early Detection of Cancer",
            "Postoperative Complications"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40537577/",
        "source_type": "Global"
    },
    {
        "pmid": "40530860",
        "title": "Performance of direct-from-blood-culture disk diffusion antibiotic susceptibility testing and its impact on antibiotic adjustment in bloodstream infections at a Malaysian tertiary center.",
        "abstract": "Delayed antibiotic increase mortality bloodstream infection BSI Directfrombloodculture disk diffusion antibiotic susceptibility testing dAST forecast susceptibility earlier conventional susceptibility testing cAST study aimed evaluate dAST performance impact antibiotic adjustment BSI Malaysian singlecenter prospective study dAST performed interpreted according breakpoints Clinical Laboratory Standards Institute CLSI guidelines turnaround time TAT categorical agreement CA predictive value dAST susceptibility cAST determined among positive blood culture PBC November 2022 November 2023 active AWaRe antibiotic administered dAST result compared 318 PBCs median TAT earlier cAST 35 hours CA 3561 organismantibiotics combination 915 36 major error VME 33 major error ME 52 minor error mE dAST achieved CA 90 iStaphylococcus aureusi cefoxitin 985 iPseudomonas aeruginosai ceftazidime 100 iAcinetobacter baumanniii ampicillinsulbactam 100 Enterobacterales combination 90 including ampicillin 951 ceftriaxone 957 meropenem 957 though aminopenicillininhibitor combination 80 error attributed mEs Among 159 BSI prescribing active antibiotic improved significantly following dAST 730 versus 893 iPi  0001 Access antibiotic 358 versus 352 iPi  0188 dAST good CAs antibiotics allowing earlier improvement active antibiotics modest change Access antibiotic prescribing reveals practice gap need antimicrobial stewardship Global death attributable antimicrobial resistance rising Hence rapid susceptibility testing essential timely antibiotic deescalation mitigate antimicrobial resistance AMR development exposure broadspectrum antibiotics Compared costly advanced technology direct disk diffusion blood culture diffusion antibiotic susceptibility testing dAST affordable method quickly adopted However reliability dAST informing susceptibility mainly reported Western country scarcely regions including Southeast Asia AMR burden high study Malaysia add insight performance dAST potential apply similar resourcelimited setting region Furthermore assessing dASTs influence antibiotic prescribing identifies gap implementation guide area improvement optimizing clinical utility",
        "mesh_terms": [
            "Humans",
            "Anti-Bacterial Agents",
            "Malaysia",
            "Tertiary Care Centers",
            "Prospective Studies",
            "Bacteremia",
            "Blood Culture",
            "Disk Diffusion Antimicrobial Tests",
            "Bacteria",
            "Microbial Sensitivity Tests",
            "Sepsis",
            "Male",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40530860/",
        "source_type": "Global"
    },
    {
        "pmid": "40526640",
        "title": "Diversity and antibiotic susceptibility profiles of bacterial isolates from wound infections in patients at the surgical unit of Kisii teaching and referral hospital, Kenya.",
        "abstract": "Antimicrobial resistance AMR pose growing threat global health wound infection serving significant reservoir multidrugresistant bacteria Understanding sociodemographic clinical microbiological characteristic wound infection critical effective intervention strategy resourcelimited settings Thus study aimed evaluate diversity bacterial profiles resistance pattern wound infection Kisii Teaching Referral Hospital this total 118 bacterial isolates wound swab collected 149 patient met eligibility criteria May November 2024 sample cultured analysed using standard microbiological technique antibiotic susceptibility testing according Clinical Laboratory Standards Institute guidelines Resistance gene associated Vancomycin resistance Staphylococcus aureus Staphylococcus xylosus also investigated using polymerase chain reaction PCR appropriate primer agarose gel electrophoresis result revealed predominance male patient n  79 5302 avulsion n  50 3400 wound lower limb n  63 4229 Escherichia coli n  33 2797 Enterobacter gergoviae n  20 1695 Staphylococcus aureus n  18 1525 Staphylococcus xylosus n  18 1525 frequently isolated pathogens Alarmingly high resistance rate observed ACCESS antibiotics including CotrimoxazoleTrimethoprim n  114 97 Ampicillin n  109 92 Streptomycin n  100 85 Resistance Watch Reserve antibiotics including Vancomycin n  11 29 Ceftriaxone n  27 33 also documented particularly among Grampositive isolates Staphylococcus aureus Gramnegative pathogen like Pseudomonas aeruginosa Resistance gene VanA VanB VanC detected S aureus S xylosus underscoring role genetic mechanism resistance propagation finding highlight critical need targeted antimicrobial stewardship programme strengthened infection prevention measure highburden hospital settings Kisii Teaching Referral Hospital study underscore importance local resistance data guiding empirical therapy informs policy mitigate AMR resourcelimited contexts Moreover enhanced surveillance research alternative therapy crucial safeguarding efficacy lifesaving antibiotic improving patient care outcomes",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Kenya",
            "Adult",
            "Middle Aged",
            "Hospitals, Teaching",
            "Wound Infection",
            "Bacteria",
            "Young Adult",
            "Adolescent",
            "Aged",
            "Drug Resistance, Multiple, Bacterial",
            "Staphylococcus aureus",
            "Referral and Consultation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40526640/",
        "source_type": "Global"
    },
    {
        "pmid": "40510521",
        "title": "Multidrug-Resistant ESKAPEEc Pathogens From Bloodstream Infections in South Africa: A Cross-Sectional Study Assessing Resistance to WHO AWaRe Antibiotics.",
        "abstract": "Multidrugresistant MDR pathogens particularly member ESKAPE group iEscherichia colii collectively referred ESKAPEEc major contributor bloodstream infection BSIs pose significant treatment challenges study aimed characterize antimicrobial resistance AMR profile ESKAPEEc isolates BSIs public hospital uMgungundlovu District South Africa assess resistance World Health Organization WHO Access Watch Reserve AWaRe antibiotics November 2017 December 2018 blood sample ini  195 collected adult paediatric patient suspected BSIs Isolates identified using VITEK 2 system confirmed polymerase chain reaction PCR Antimicrobial susceptibility testing performed using KirbyBauer disk diffusion method interpreted according EUCASTCLSI guidelines multiple antibiotic resistance index MARI calculated Oneway analysis variance ANOVA used assess association MARI clinical variables including ward type facility level 195 presumptive isolates 159 confirmed ESKAPEEc frequently identified pathogen iKlebsiella pneumoniaei 289 iStaphylococcus aureusi 283 High resistance rate observed across Access Watch antibiotics including ampicillin 76 iE colii gentamicin 674 iK pneumoniaei ciprofloxacin ≥ 60 species Carbapenem resistance iAcinetobacter baumanniii reached 90 Overall 949 isolates MDR 931 MARI ≥ 02 Significant difference MARI value observed across ward group facility levels highest value recorded intensive care unit mean  067 95 CI 062072 tertiary hospital mean  064 95 CI 060068 compared regional hospital mean  052 95 CI 047057 finding reveal high burden MDR ESKAPEEc BSIs widespread resistance Watch antibiotics Targeted antimicrobial stewardship implementation microbiologyguided therapy urgently needed optimize patient outcome curb spread resistance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40510521/",
        "source_type": "Global"
    },
    {
        "pmid": "40500700",
        "title": "Comparative genomics of Acinetobacter baumannii from Egyptian healthcare settings reveals high-risk clones and resistance gene mobilization.",
        "abstract": "Acinetobacter baumannii A baumannii emerged major public health threat low middleincome country LMICs particularly Egypt due remarkable ability acquire transfer resistance genes highlighted bacterial Priority Pathogens List 2024 classification pilot study aimed characterize 18 A baumannii isolates Egyptian healthcare settings focusing clonal lineages antibiotic resistance determinants horizontal gene transfer potential presence virulence factor chromosomal mutations Antimicrobial susceptibility testing performed determine resistance profile using minimum inhibitory concentrations Wholegenome sequencing used identify βlactamase carbapenemase antibiotic resistance gene ARGs well mobile genetic element MGEs Clonal relationship among isolates assessed via core genome multilocus sequence typing cgMLST Phenotypic analysis revealed 72 isolates extensively drugresistant XDR exhibiting resistance tested antibiotic except colistin Clonal diversity analysis identified 11 Oxford sequence type STs including two novel STs ST3309supOXFsup ST3321supOXFsup six international clonal IC groups IC2 prevalent Additionally eight Pasteur STs detected ST570supPASsup frequent cgMLST analysis showed two Egyptian ST570supPASsup isolates clustered strain Saudi Arabia suggesting potential regional transmission Genomic analysis revealed widespread dissemination ARGs via MGEs particularly rep plasmid insertion sequence elements contributed significantly genomic diversity antibiotic resistance pilot study highlight clonal diversity A baumannii Egypt underscore critical role MGEs spread resistance genes Targeted genomic surveillance infection control essential curb spread highrisk resistant A baumannii clone Egyptian clinical settings",
        "mesh_terms": [
            "Acinetobacter baumannii",
            "Egypt",
            "Humans",
            "Acinetobacter Infections",
            "Anti-Bacterial Agents",
            "Pilot Projects",
            "Microbial Sensitivity Tests",
            "Drug Resistance, Multiple, Bacterial",
            "Genomics",
            "Whole Genome Sequencing",
            "Virulence Factors",
            "Genome, Bacterial",
            "Gene Transfer, Horizontal",
            "Multilocus Sequence Typing",
            "beta-Lactamases",
            "Health Facilities",
            "Bacterial Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40500700/",
        "source_type": "Global"
    },
    {
        "pmid": "40491668",
        "title": "Adherence to WHO/INRUD prescription indicators in public hospitals: evidence from the Ashanti Region, Ghana.",
        "abstract": "Rational prescribing optimizes medicine use reduces costs improves patient outcomes However adherence rational prescribing practice varies particularly low middleincome country like Ghana healthcare system differ across urban periurban rural settings study assessed adherence WHOINRUD prescribing indicator public hospital determined hospitals Index Rational Drug Prescribing IRDP retrospective descriptive study conducted 25 public hospital across rural periurban urban setting Ashanti Region Ghana Data 5091 patient encounter analyzed assess prescribing indicators including average number medicine per encounter generic prescribing adherence Essential Medicines List EML antibiotic use injection prescribing IRDP score calculated geographic comparison performed using analysis variance ANOVA ipi  005 considered statistically significant hospital met target 2 medicine per encounter regional average 363 ± 062 Generic prescribing averaged 7226 EML adherence 9185 hospital achieving 100 Antibiotic prescribing exceeded 30 target averaging 6084 Injection use aligned best standard average 1342 22 25 hospital meeting 20 threshold regional IRDP 367 rural hospital scoring lowest 363 followed periurban 364 urban hospital 381 significant geographic difference IRDP score observed ipi  005 injection use aligns standards gap remain generic prescribing antibiotic use EML adherence Strengthening prescriber training antimicrobial stewardship programs policy enforcement essential improving prescribing practice patient outcome public hospital Ashanti Region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40491668/",
        "source_type": "Global"
    },
    {
        "pmid": "40487777",
        "title": "Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational study.",
        "abstract": "Since 2009 European Centre Disease Prevention Control ECDC coordinated European Gonococcal Antimicrobial Surveillance Programme EuroGASP monitor antimicrobial resistance AMR iNeisseria gonorrhoeaei across European Union European Economic Area EUEEA aim study report EuroGASP 2022 data compare recently published EuroGASP data from 2016 2019 identify change AMR risk group AMR observational study 23 EUEEA country submitted AMR data gonococcal isolates 2022 linked patient epidemiological data European Surveillance System TESSy Statistical analysis Ztest used determine significance difference epidemiological data proportion AMR isolates 2022 versus 2019 2016 risk factor associated AMR isolates assessed using univariate multivariable logistic regression analysis odds ratios Ceftriaxone resistance 2022 003 13008 remained low 006 23239 2019 cefixime resistance 03 103008 decreased 08 263239 2019 Azithromycin resistance 249 7493008 ciprofloxacin resistance 658 19803008 increased 90 2843159 574 16652884 respectively 2019 marked increase number 575 502 2019 proportion 192 158 2019 female gonorrhoea case also identified 2022 univariate analysis azithromycin resistance associated oropharyngeal OR 167 CI 128218 p  00001 anorectal infection OR 138 CI 108176 p  00094 menwhohavesexwithmen MSM OR 388 CI 280537 p  00001 female 171 CI 121241 p  00022 multivariable logistic regression model azithromycin resistance MSM remained associated OR 285 CI 133473 p  00040 ceftriaxone resistance remains sporadically detected EuroGASP increase report occasional ceftriaxone resistance EUEEA country substantial increase azithromycin resistance underscore urgent need enhanced AMR surveillance EuroGASP data crucial refining treatment guideline mitigating spread AMR gonococcal strains Novel effective antimicrobial gonorrhoea treatment remain imperative ECDC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40487777/",
        "source_type": "Global"
    },
    {
        "pmid": "40486980",
        "title": "Antibiotic dispensing practices in community pharmacies: Implications for antimicrobial stewardship in resource-constrained settings.",
        "abstract": "Overthecounter antibiotic sale communitypharmacies significantly drive antimicrobial resistance AMR low middleincome country LMICs due inappropriate use early treatment discontinuation Bangladesh community pharmacies dispense 566  antibiotic without prescriptions serve first healthseeking touchpoint yet conventional stewardship strategy often overlook informal providers heightening AMR risks study examines drugsellers understanding practice towards antibiotic dispensing compare symptomatictreatment practice Bangladeshs Standard Treatment Guidelines STGs understand extent antibiotic misuse crosssectional survey two urban two rural area Bangladesh involved 120 drugsellers 30 randomly selected pharmacy per site Knowledge compared drugsellers pharmacydispensing training without training suggested treatment two simulated healthsymptomsupper respiratorytract gastrointestinal infectionswere evaluated STGs determine extent misuse drugsellers aged 4150 year 350  392  holding bachelors degree higher 658  pharmacydispensing training overall knowledge score antibiotic use AMR moderate 602  57 10 325  scoring ≤4 indicating poor knowledge trained drugsellers scored significantly better ipi  0008 half 575  unaware antibiotic dispensing policies though 758  acknowledged link AMR antibiotic use simulated upper respiratorytract infections 542  recommended single antibiotic908  Watch 92  Access per WHOAWaRe classificationwith 662  prescription deviating guideline due inappropriate selection dosage gastrointestinal infections 558  recommended single antibiotic 403  Watch 597  Access 821  deviated guidelines Additionally 267  recommended two antibiotic 516  Watch 484  Access inconsistent guideline recommendations simulated symptoms significant difference observed drug sellers treatment practice based knowledge level study highlight need contextspecific policy regulatory measure informal healthcare settings improving drugsellers knowledge vital antimicrobial stewardship LMICs like Bangladesh alone insufficient due market competition weak regulation patientdriven demand Thus curbing inappropriate antibiotic use community level requires stronger enforcement multifaceted contexttailored interventionsincluding public awareness targeted training marketresponsive strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40486980/",
        "source_type": "Global"
    },
    {
        "pmid": "40483604",
        "title": "Mapping the hidden epidemic: A scoping review of sexually transmitted diseases in Southeast Asia.",
        "abstract": "bBackgroundb Sexually transmitted disease STDs pose significant global health challenge Southeast Asia bearing disproportionately high burden due sociodemographic vulnerabilities disparity healthcare access prevailing cultural stigmas Despite growing research interest region comprehensive synthesis disease burden risk factors intervention strategy remains limitedbObjectivesb study aimed systematically review research trends study populations pathogen distribution STDs Southeast Asia identify evidence gap inform future policy intervention strategiesbMethodsb systematic literature search conducted using Scopus Web Science PubMed database accordance PRISMA guidelines Eligible study focusing STDs Southeast Asia included highrisk population men sex men MSM sex workers youth heterosexual men women transgender individuals people living HIV PLHIV review encompassed key STDs including HIVAIDS syphilis gonorrhea chlamydia HPV trichomoniasis hepatitis B  CbResultsb 2867 records 58 study met inclusion criteria HIVAIDS frequently studied STD 80 bacterial STDs transgender population significantly underrepresented study employed crosssectional design 60 longitudinal interventional studies Geographically research concentrated Malaysia Thailand Singapore limited representation Cambodia Vietnam IndonesiabDiscussionb finding underscore substantial research gaps particularly bacterial STDs study involving heterosexual transgender populations application interventionbased designs Inconsistencies reporting standard population definition limit comparability finding across studiesbConclusionb review highlight need inclusive methodologically diverse research STDs Southeast Asia Future effort prioritize standardized data collection frameworks improved surveillance systems greater emphasis intervention study strengthen evidencebased public health response region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40483604/",
        "source_type": "Global"
    },
    {
        "pmid": "40467884",
        "title": "Characterization of a plasmid dependent DNA phage targeting Escherichia coli harboring a conjugative plasmid and its impact on gut microbiota.",
        "abstract": "emergence spread antimicrobial resistance bacteria pose significant global threat public health One main driver spread horizontal transfer antimicrobial resistance gene via conjugative plasmids study isolated novel phage PDP46 specifically target Escherichia coli strain carrying conjugative plasmid encodes antibiotic resistance genes PDP46 requires conjugative IncF plasmid infection enabling selectively target bacterial strain capable plasmidmediated gene transfer Phylogenetic analysis based major capsid protein revealed PDP46 cluster several phage use Oantigen receptor However tail fiber PDP46 differs clustered phages suggesting tail fiber structure PDP46 may play key role plasmiddependent infectivity Furthermore explore therapeutic potential evaluated PDP46s effect gut microbiota using vitro human fecal incubation model finding suggest phage PDP46 could inhibit growth target bacteria harboring conjugative plasmid without disrupting overall microbial diversity inhibiting growth donor cell carrying antibiotic resistanceassociated plasmids PDP46 may serve targeted gut microbiota modulator",
        "mesh_terms": [
            "Escherichia coli",
            "Plasmids",
            "Gastrointestinal Microbiome",
            "Humans",
            "Phylogeny",
            "Bacteriophages",
            "Conjugation, Genetic",
            "Feces",
            "Gene Transfer, Horizontal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40467884/",
        "source_type": "Global"
    },
    {
        "pmid": "40459795",
        "title": "Characterization of multidrug-resistant Escherichia coli isolated from clinical (UPEC) and environmental samples.",
        "abstract": "Escherichia coli E coli significant cause urinary tract infection UTIs study total 1040 sample comprising treated Wastewater 57 Nile River water 400 urine suspected UTI patient 583 collected September 2019 March 2020 E coli prevalent Wastewater 842 river water 633 335 urine samples extendedspectrum βlactamaseproducing E coli ESBLEC isolates fully resistant penicillin cephems Multidrug resistance MDR found 707 Wastewater 87 river isolates notable resistance ampicillinsulbactam sulfamethoxazoletrimethoprim ciprofloxacin Clinical isolates showed 625 MDR remained susceptible primarily ciprofloxacin entirely meropenem Phylogenetic analysis revealed diverse chlorinetolerant Uropathogenic E coli strains suggesting environmental spread result highlight wastewater treatment plant key reservoir MDR E coli stress need better surveillance control Egypt",
        "mesh_terms": [
            "Drug Resistance, Multiple, Bacterial",
            "Humans",
            "Wastewater",
            "Anti-Bacterial Agents",
            "Escherichia coli",
            "Microbial Sensitivity Tests",
            "Urinary Tract Infections",
            "Escherichia coli Infections",
            "Rivers",
            "Phylogeny",
            "Egypt",
            "Ciprofloxacin",
            "beta-Lactamases",
            "Water Microbiology"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40459795/",
        "source_type": "Global"
    },
    {
        "pmid": "40442753",
        "title": "Drug resistance and genetic transmission characteristics of HIV-1 CRF55_01B in people living with HIV/AIDS (PLWHA) in Henan Province, China.",
        "abstract": "Among many CRFs CRF5501B first CRF01AE subtype B recombinant strain identified around 2013 among men sex men MSM Shenzhen China rapid spreading throughout country CRF5501B attracted much attention recent years study aimed analyze prevalence drug resistance transmission characteristic people living HIVAIDS PLWHA Henan province China pay particular attention group individual reduce incidence drug resistance Two hundred fortyfive CRF5501Binfected individuals including 141 treatmentnaïve 104 treatmentexperienced individuals enrolled treatmentnaïve individuals 638 9141 harboured NRTI DRMs 1915 27141 harboured NNRTI DRMs except V179ED treatmentexperienced individuals 200 2100 harboured INSTI DRMs 8269 86104 harboured NRTI DRMs 8846 92104 harboured NNRTI DRMs except V179ED overall prevalence ADR 8942 93104 prevalence PDR 1986 28141 total 23 transmission clusters accounting 3755 92245 total sequences identified cluster ranged size 2 19 15 6522 3 sequences High prevalence DRMs drug resistance observed CRF5501B treatmentnaïve treatmentexperienced individuals particular attention paid group individual reduce incidence drug resistance",
        "mesh_terms": [
            "Humans",
            "China",
            "Male",
            "HIV-1",
            "Drug Resistance, Viral",
            "HIV Infections",
            "Adult",
            "Middle Aged",
            "Female",
            "Prevalence",
            "Genotype",
            "Anti-HIV Agents",
            "Young Adult",
            "Phylogeny",
            "Homosexuality, Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40442753/",
        "source_type": "Global"
    },
    {
        "pmid": "40430158",
        "title": "Susceptibility of <i>Lactobacillaceae</i> Strains to Aminoglycoside Antibiotics in the Light of EFSA Guidelines.",
        "abstract": "iLactobacillaceaei large family bacteria probiotic strain often originate Microorganisms used feed additive EU must meet number formal criteria concern antimicrobial susceptibility study determined susceptibility 19 reference strain 121 wildtype strain iLactobacillaceaei aminoglycoside antibiotic using broth microdilution method based ISO 109322010IDF 2232010 standard Strains categorized resistant susceptible according European Food Safety Authority EFSA guidelines Resistance gene detected whole genome sequence WGS analysis PCR MICs read 48 h incubation showed 368 reference strain resistant kanamycin 263 streptomycin 53 gentamicin aminoglycoside resistance gene detected genome many 932 field isolates iLigilactobacillus salivariusi 85 iLigilactobacillus agilisi 588 iLactiplantibacillus plantarumi classified resistant kanamycin iaac6Ieaph2Iai gene detected two isolates six 12 streptomycinresistant strains iant6Iai gene identified usually coexisted ispwi gene Three isolates high neomycin MICs harbored iant4Iai gene iLactobacillus gallinarumi strain LMG 9435 characterized streptomycin MIC value  1024 µgmL potential resistancecausing mutation irpsLi gene Lys56 → Arg detected result study indicate genus iLactobacillaceaei particular iL salivariusi iL agilisi exhibit natural resistance aminoglycoside antibiotics mainly kanamycin Therefore need update EFSA guideline antimicrobial susceptibility testing iLactobacillaceaei strain lacking resistance gene andor chromosomal mutation considered resistant",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40430158/",
        "source_type": "Global"
    },
    {
        "pmid": "40426162",
        "title": "Interprofessional training in medical education: competency, collaboration, and multi-level analysis across seven governorates, Egypt.",
        "abstract": "Interprofessional Education IPE essential improving patient outcome promoting teamwork collaboration among healthcare professionals study aimed assess impact IPE developing clinical competency collaborative practice Egyptian intensive care unit ICUs core module focused managing antibiotic resistance venous thromboembolism VTE mechanical ventilation MV chosen high prevalence Egyptian ICUs significant impact patient outcomes IPE program implemented across seven governorates involving 16 hospital multidisciplinary ICU teams conducted two consecutive fourmonth waves covering three core modules Participants included physicians clinical pharmacists ICU nurses enhance efficacy blended learning approach combined virtual webinars casebased discussions inperson workshops Data collection included pre posttests posttraining satisfaction survey Interdisciplinary Education Perception Scale IEPS assess competency improvements IPE program included 157 participants 79 wave 1 78 wave 2 Physicians mostly male 472 older  40 years clinical pharmacist ICU nurse younger predominantly female 896 757 respectively exam performance clinical pharmacist highest excellence rate 224 ICU nurse highest failure rate 405 Posttraining interprofessional competence improved significantly physician showing greatest competency gain p  005 clinical pharmacist playing key role antibiotic resistance management p  0029 Overall satisfaction high across modules increasing 798 Module 1 905 Module 3 Higher satisfaction observed among female up 895 participant aged 3040 926 Module 2 received sufficient program information p  0011 lecturer median score rated consistently 50 material satisfaction median score varied 4048 IPE program improved interprofessional collaboration clinical competency despite challenge participant dropout scheduling conflicts engagement virtual sessions addressing issue like antimicrobial resistance critical care management provides practical model improving healthcare outcomes particularly resourcelimited settings program preliminary step plan expand hospital Egypt conduct research longterm impact patient outcome potential replication healthcare system worldwide applicable",
        "mesh_terms": [
            "Humans",
            "Egypt",
            "Female",
            "Male",
            "Clinical Competence",
            "Adult",
            "Interprofessional Education",
            "Cooperative Behavior",
            "Intensive Care Units",
            "Middle Aged",
            "Interprofessional Relations",
            "Education, Medical",
            "Patient Care Team"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40426162/",
        "source_type": "Global"
    },
    {
        "pmid": "40416697",
        "title": "Prevalence and epidemiology of <i>Mycoplasma genitalium</i> and the absence of macrolide resistance in <i>M. genitalium</i> among pregnant women attending antenatal care in Zambia.",
        "abstract": "iMycoplasma genitaliumi MG sexually transmitted bacterium public health importance associated genitourinary disorders adverse reproductive perinatal outcomes Global data MG prevalence antimicrobial resistance AMR primarily available highincome countries whereas dearth information resourceconstrained setting including subSaharan Africa Furthermore international data MG rate AMR antenatal population scarce Understanding MG prevalence AMR pattern crucial developing effective public health strategy treatment guidelines aim study investigate prevalence epidemiology MG presence macrolide resistanceassociated mutation MRAMs among pregnant woman attending antenatal care facility Zambia crosssectional study conducted four antenatal care facility Nchelenge Zambia among 1021 pregnant women Vaginal swab collected tested using Aptima iMycoplasma genitaliumi assay Aptima Combo 2 assay Aptima iTrichomonas vaginalisi assay Panther System Hologic MGpositive sample analyzed MRAMs using ResistancePlus™ MG assay SpeeDx prevalence MG 126 127 1005 valid samples among pregnant women 12 MGpositive woman 94 symptom genitourinary infection similar frequency genitourinary symptom among MGnegative woman 61 rate iChlamydia trachomatis Neisseria gonorrhoeae T vaginalisi HIV seropositivity 74 83 230 86 respectively MG infection significantly associated presence tested sexually transmitted infection HIV seropositivity detection rate iC trachomatis N gonorrhoeae T vaginalisi HIV seropositivity significantly higher MGpositive MGnegative woman 151 vs 62 150 vs 75 323 vs 220 143 vs 75 respectively ResistancePlus™ MG assay detected MG 661 84127 sample positive Aptima iM genitaliumi assay however MRAMs detected 23S rRNA gene 84 samples study emphasizes high prevalence MG among pregnant woman Zambia also lack MRAMs MG finding suggest azithromycin remains efficacious treatment option MG population Nevertheless continuous surveillance judicious macrolide use maintain treatment efficacy imperative research sustained monitoring MG essential inform public health strategy clinical guideline Zambia similar setting worldwide",
        "mesh_terms": [
            "Humans",
            "Female",
            "Zambia",
            "Mycoplasma genitalium",
            "Pregnancy",
            "Cross-Sectional Studies",
            "Prevalence",
            "Adult",
            "Mycoplasma Infections",
            "Macrolides",
            "Prenatal Care",
            "Drug Resistance, Bacterial",
            "Anti-Bacterial Agents",
            "Pregnancy Complications, Infectious",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40416697/",
        "source_type": "Global"
    },
    {
        "pmid": "40404795",
        "title": "HIV-1 subtype distribution and drug resistance profiles among PLWHA with detectable viremia in Henan Province, China, 2023.",
        "abstract": "China Henan Province region high HIV burden Furthermore drug resistance DR among people living HIVAIDS PLWHA antiretroviral therapy ART becoming critical barrier achieving viral suppression Monitoring DR PLWHA detectable viremia ART crucial especially given widespread use NNRTI NRTI historically backbone Chinas national ART program due affordability availability study plasma sample PLWHA viral load VL ≥ 40 copiesmL ≥ 6 month ART January 2023 December 2023 collected genotypic DR testing 804 individual detectable viremia total 14 HIV1 subtypes detected top five subtypes B 5597 450804 CRF01AE 2214 178804 CRF07BC 1542 124804 CFR5501B 336 27804 CRF08BC 100 8804 DR analysis revealed prevalence 6779 545804 resistance rate nonnucleoside reverse transcriptase inhibitor NNRTIs nucleoside reverse transcriptase inhibitor NRTIs protease inhibitor PIs integrase strand transfer inhibitor INSTIs 6294 506804 5323 428804 734 59804 398 32804 respectively prevalence DR among PLWHA ≥ 200 copiesmL 4063 1332 6891 532772 respectively Multivariate regression analysis showed age  29 year 4049 years baseline CD4 count  500 cellsµL current VL 10sup3sup10sup5sup copiesmL initial ART regimen NRTIs  NNRTIs closely associated occurrence DR finding highlight urgent need expanded access drug resistance testing adoption WHOrecommended regimens dolutegravir DTG mitigate growing threat DR result suggest drug resistance testing applied PLWHA detectable viremia treatment strategy optimized align global guidelines",
        "mesh_terms": [
            "Humans",
            "HIV-1",
            "China",
            "Male",
            "Female",
            "Adult",
            "Drug Resistance, Viral",
            "Viremia",
            "HIV Infections",
            "Middle Aged",
            "Viral Load",
            "Anti-HIV Agents",
            "Genotype",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40404795/",
        "source_type": "Global"
    },
    {
        "pmid": "40395974",
        "title": "Current status and future direction of antimicrobial stewardship programs and antibiotic prescribing in primary care hospitals in Zambia.",
        "abstract": "Antimicrobial Stewardship Programs ASPs intended optimize antibiotic use effective informed current status pattern antibiotic utilisation Zambias primary healthcare PHC settings data ASPs antibiotic utilisation inadequate guide improvements first step study assessed antibiotic prescribing ASP core element among PHC firstlevel hospital FLHs Zambia point prevalence survey conducted five FLHs Lusaka using GlobalPPSsup®sup protocol Hospital ASP core element evaluated included hospital leadership commitment accountability pharmacy expertise action tracking reporting education Antibiotic use prevalence 798 146183 total 220 antibiotic prescription encounter recorded among inpatients ceftriaxone J01DD04 Watch 500 prescribed 900 202 antibiotic prescription targeted suspected communityacquired infections 368 81 compliant national treatment guidelines ASP core element implementation 360 16245 two hospital achieving 500 deficient core element accountability action tracking reporting ASP implementation Zambias FLHs providing PHC suboptimal high antibiotic prescribing rates frequent use broadspectrum Watch group antibiotics low compliance national treatment guidelines key way forward ASPs Zambias PHC require strengthening adapting AWaRe recommendation improving accountability actions tracking reporting antibiotic use improve stewardship practice reduce AMR",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40395974/",
        "source_type": "Global"
    },
    {
        "pmid": "40389957",
        "title": "Salvage therapy with an Albuvirtide-based antiretroviral regimen for multi-drug resistant HIV and drug-resistant HBV with renal impairment: a case report.",
        "abstract": "clinical management HIV particularly context multidrug resistance MDR coinfections hepatitis B virus HBV notably complex present case study patient multidrug resistant HIV coinfected drugresistant HBV suffered renal insufficiency employed optimized regimen based fusion inhibitor Albuvirtide ABT combined highly effective low nephrotoxicity antiviral drug HBV approach ultimately achieved effective suppression HIV HBV 58yearold male diagnosed HIV 1997 coinfected HBV experienced renal insufficiency Due poor adherence developed resistance nucleoside nonnucleoside reverse transcriptase inhibitors protease inhibitor nearly two decades necessitating frequent modification ART regimen 2019 HIV RNA rebounded 1120 copiesmL prompting resistance testing revealed highlevel resistance Elvitegravir EVG intermediate resistance Raltegravir RAL potential lowlevel resistance Bictegravir BIC dolutegravir DTG led strategic overhaul ART ABT  EmtricitabineTenofovir Alafenamide FTCTAF  doubledose DTG resulting significant suppression HIV Concurrently HBV suppression renal function wellmaintained case underscore potential value individualized treatment strategy patient multidrugresistant HIV HBV coinfection complicated renal impairment observed virological control following use novel agent Albuvirtide ABT combination secondgeneration integrase strand transfer inhibitor INSTIs like DTG alongside renalsparing antivirals highlight importance designing optimized regimen based resistance profile renal function personalized adaptive therapeutic approach may offer clinical benefit similarly complex scenarios",
        "mesh_terms": [
            "Humans",
            "Male",
            "Middle Aged",
            "HIV Infections",
            "Salvage Therapy",
            "Drug Resistance, Multiple, Viral",
            "Coinfection",
            "Renal Insufficiency",
            "Hepatitis B virus",
            "Hepatitis B",
            "Antiviral Agents",
            "Anti-HIV Agents",
            "HIV-1",
            "Tenofovir",
            "Alanine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40389957/",
        "source_type": "Global"
    },
    {
        "pmid": "40389858",
        "title": "Emerging antibiotic resistance in bacterial bloodstream infections: a clinical study at the Holy Family Hospital, Nkawkaw, Ghana.",
        "abstract": "Bacteraemia critical bloodstream infection caused various bacterial pathogens pose significant health challenges particularly compounded antibiotic resistance current study determined prevalence bloodstream bacterial isolates antibioticresistant pattern Holy Family Hospital Nkawkaw Ghana spanning sixyear period hospitalbased retrospective study carried review record bacterial isolates bloodstream infection antibioticresistant pattern among patient visited Holy Family Hospital 2018 2023 data collected Excel sheet version 2021 cleaned exported appropriate statistical software SPSS v26 statistical analysis Pvalue less 005 considered statistically significant analyses 3228 record study majority 660 found 1 year age 186 aged 110 years prevalence bacteraemia 87 95 CI 7897 Klebsiella specie found prevalent 302 followed S aureus 260 highest level antibiotic resistance detected tetracycline 945 penicillin 923 chloramphenicol 909 Also significant resistance also found vancomycin 883 cefuroxime 865 cloxacillin 844 Conversely amikacin demonstrated highest susceptibility rate 905 followed ciprofloxacin 750 study highlight significant public health burden posed bacteraemia growing challenge antibiotic resistance prevalence bacteraemia particularly caused Gramnegative organism Klebsiella specie E coli underscore need targeted intervention improve infection control healthcare settings",
        "mesh_terms": [
            "Humans",
            "Ghana",
            "Retrospective Studies",
            "Child, Preschool",
            "Bacteremia",
            "Infant",
            "Anti-Bacterial Agents",
            "Child",
            "Female",
            "Male",
            "Adolescent",
            "Adult",
            "Middle Aged",
            "Prevalence",
            "Drug Resistance, Bacterial",
            "Young Adult",
            "Aged",
            "Microbial Sensitivity Tests",
            "Bacteria",
            "Infant, Newborn",
            "Aged, 80 and over",
            "Hospitals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40389858/",
        "source_type": "Global"
    },
    {
        "pmid": "40389319",
        "title": "Antimicrobial prophylaxis for endourological procedures in Jordanian hospitals: a multi-centre qualitative study.",
        "abstract": "explore urologists perception barrier to facilitator of adherence international antimicrobial prophylaxis AP guideline endourological procedure Jordan identify strategy optimise guidelineconcordant AP prescribing present study qualitative study undertaken semistructured interview inductive thematic analysis Study result reported per Consolidated Criteria Reporting Qualitative Research Secondary tertiary care across multiple public private academic hospital Jordan Nineteen practising urologist all male median age 32 years IQR 8 nine residents 10 specialists routinely prescribe AP endourological procedures Participants recruited via convenience snowball sampling interviewed thematic saturation reached applicable main outcome theme describing perceived barrier guideline adherence potential facilitator support appropriate AP use Participants identified several barriers 1 patient level strong expectation antibiotic postprocedure concern proceduresite hygiene 2 clinician level fear postoperative infection litigation lack familiarity updated guidance doubt applying international guideline locally 3 system level hierarchical prescribing dynamics referral communication gaps high workload time pressures concern sterilisation practices Facilitators included targeted professional training regular guideline update urologists development local AP guideline informed local resistance data enhanced patient education campaign active involvement clinical pharmacist preoperative antibiotic review auditing Urologists Jordan face multifaceted barrier AP guideline adherence Future stewardship programme use insight study develop locally tailored guidelines targeted clinician training pharmacistled audits Pilot testing metric prescribing rates guideline concordance antibiotic consumption postoperative infection incidence essential validate impact wider implementation",
        "mesh_terms": [
            "Humans",
            "Jordan",
            "Qualitative Research",
            "Guideline Adherence",
            "Male",
            "Adult",
            "Antibiotic Prophylaxis",
            "Practice Patterns, Physicians'",
            "Urologic Surgical Procedures",
            "Anti-Bacterial Agents",
            "Practice Guidelines as Topic",
            "Attitude of Health Personnel",
            "Urologists",
            "Interviews as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40389319/",
        "source_type": "Global"
    },
    {
        "pmid": "40375963",
        "title": "Antibiotic Prophylaxis in Patients with Joint Prostheses: Variability in Dentists' Practices and the Need for Guidance.",
        "abstract": "increasing life expectancy incidence degenerative inflammatory joint disease continues rise condition major indication orthopedic prostheses pose risk postoperative complications particularly infection orthopedic prosthesis IPO Dental infection considered potential source infections recommendation regarding use antibiotic prophylaxis AP dental procedure evolved time Current guideline discourage routine use AP study aim assess knowledge attitudes practice KAP privatesector dentist city Rabat Temara Salé Morocco regarding dental management patient orthopedic prostheses particularly use AP anonymous 21question survey distributed 310 dentist practicing cities collected response analyzed using JamoviR software version 2325 significance threshold set p  005 Chisquare Fishers exact test employed compare different groups 310 distributed questionnaires 102 valid response retained response rate 329 Among respondents 539 considered patient joint prosthesis risk infection yet 471 reported prescribing AP Female practitioner 20 year experience significantly likely prescribe AP p0047 p0002 respectively Dentists consult guideline attend professional conference also prone prescribing AP endodontic procedure p0017 p0018 study reveals inconsistent knowledge practice among dentist regarding AP use patient joint prostheses Given misalignment current guideline influence outdated source information targeted educational intervention updated clinical guideline urgently needed promote evidencebased practices Clear standardized guideline also essential prevent unjustified overprescription antibiotic address growing concern antimicrobial resistance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40375963/",
        "source_type": "Global"
    },
    {
        "pmid": "40359214",
        "title": "Gram-negative bacterial sepsis, antimicrobial susceptibility pattern and treatment outcomes at two neonatal intensive care units in Addis Ababa, Ethiopia: A retrospective observational study.",
        "abstract": "Neonatal sepsis leading cause mortality morbidity improve clinical outcome neonate sepsis treatment based bacteriological identification antibiotic susceptibility study aim assess proportion culturepositive gramnegative bacteria GNB antibiotic susceptibility patterns treatment outcome neonatal sepsis two neonatal intensive care unit NICUs Addis Ababa retrospective observational study conducted among gramnegative sepsis suspected neonate admitted Zewditu Memorial Hospital Tikur Anbessa Specialized Hospital NICUs January December 2023 neonate suspected sepsis included study Standard microbiological culture biochemical test used identify bacterial specie KirbyBauer disc diffusion assay using MuellerHinton agar employed test antimicrobial susceptibility bacterial isolates per Clinical Laboratory Standard Institute guidelines Descriptive statistic used describe study variables Bivariable multivariable logistic regression analysis used identify factor associated treatment outcome neonatal sepsis pvalue  005 set statistical significance total 933 neonate diagnosed sepsis study period 166 neonate enrolled study gramnegative sepsis 84 51 female 97 58 early onset sepsis median length hospital stay nine day interquartile range 16 days predominant GNB identified Klebsiella spp n  89 49 followed Acinetobacter spp n  38 21 Escherichia coli n  19 11 hospitals Klebsiella spp resistant routinely prescribed antibiotics n  68 89 resistant ceftriaxone n  56 89 cefepime n  60 75 gentamicin Lower rate resistance recorded antibiotic ciprofloxacin n  12 18 ertapenem n  11 16 meropenem n  9 13 amikacin n  3 4 total 92 55 neonate GNB isolated current study multidrugresistant MDR organisms study found newborn MDR infection five time likely experience poor treatment outcome compared nonresistant strain AOR 523 95 CI 259 1111 addition newborn stayed less seven days compared spent seven day hospital four time AOR 416 95 CI 20901 likely experience poor health outcomes Klebsiella spp common GNB isolated NICUs half neonatal sepsis caused MDR organism associated significant poor treatment outcomes high prevalence MDRgramnegative bacteremia alarming highlight need implementation routine surveillance infection control measure decrease morbidity mortality combat development antimicrobial resistance",
        "mesh_terms": [
            "Humans",
            "Ethiopia",
            "Retrospective Studies",
            "Infant, Newborn",
            "Intensive Care Units, Neonatal",
            "Female",
            "Male",
            "Anti-Bacterial Agents",
            "Gram-Negative Bacteria",
            "Microbial Sensitivity Tests",
            "Gram-Negative Bacterial Infections",
            "Neonatal Sepsis",
            "Treatment Outcome",
            "Drug Resistance, Bacterial",
            "Sepsis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40359214/",
        "source_type": "Global"
    },
    {
        "pmid": "40357959",
        "title": "Analysis of Neisseria gonorrhoeae susceptibility trends (MIC creep) from North India: A 15-years' experience!",
        "abstract": "Background Neisseria gonorrhoeae NG highly transformable strict human pathogen potential evolve superbug Resourcelimited setting like rely syndromic diagnostic approach recommended adopted National AIDS Control Organisation NACO management sexually transmitted infection STIs Grey kit comprising cefixime 400 mg azithromycin 1 gm recommended genitourinary discharge India Aim objective study examine putative change minimum inhibitory concentration MICs ceftriaxonecefixime azithromycin ∼15year period assess need dosage adjustment Methods clinical isolates NG obtained patient attending STI clinic hospital included study MIC penicillin tetracycline ciprofloxacin ceftriaxone cefixime azithromycin spectinomycin determined using Etest method result interpreted according Calibrated Dichotomous Sensitivity CDS criterion except azithromycin up 2011 cefixime Clinical  Laboratory Standards Institute CLSI guideline used analysed data year 20082012 vs 20132017 examined limited data available thereafter June 2023 in light COVID MIC50 MIC90 MIC value stop growth 50 90 bacterial isolates respectively data analysed determination MIC creep Results total 183 NG isolates collected study period 151 20082017 32 2018 onwards isolates male patient presenting urethritis High resistance level observed penicillin tetracycline ciprofloxacin decreased susceptibility ceftriaxone cefixime remained 10 resistance azithromycin 5 Notably ceftriaxone resistance detected ∼15year period significant increase MIC MIC creep observed ceftriaxone azithromycin two isolates showed concurrent resistance azithromycin decreased susceptibility ceftriaxone isolates susceptible spectinomycin Limitations clinical isolates obtained single site number limited paucity data COVID19 pandemic due limited clinical service offered Conclusion appears immediate threat therapy currently used syndromic management genitourinary discharge However MICbased monitoring crucial antimicrobial imperative",
        "mesh_terms": [
            "Humans",
            "Neisseria gonorrhoeae",
            "India",
            "Microbial Sensitivity Tests",
            "Anti-Bacterial Agents",
            "Azithromycin",
            "Gonorrhea",
            "Cefixime",
            "Ceftriaxone",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40357959/",
        "source_type": "Global"
    },
    {
        "pmid": "40342464",
        "title": "Temporal Trends in the Management and Mortality Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales: A Cohort Study.",
        "abstract": "Introduction iKlebsiella pneumoniaei carbapenemaseproducing Enterobacterales KPCCPE significant cause healthcareassociated infections characterized highlevel resistance betalactam antibiotic limited therapeutic options study aimed analyze epidemiological trends clinical management mortality associated KPCCPE infection decade highlighting variation incidence treatment pattern COVID19 pandemic Methods retrospective singlecenter cohort study conducted tertiary Portuguese hospital analyzing data August 2015 June 2024 Patients microbiologically confirmed KPCCPE infection included study Epidemiological clinical therapeutic data extracted analyzed using descriptive statistic logistic regression identify risk factor mortality Results Among 6259 patient KPCCPE isolates 483 77 developed infections Infection rate peaked 2016 2023 decline COVID19 pandemic 30day mortality rate 28 bloodstream infection BSIs odds ratio OR164 p0028 admission intensive care unit ICU significantly associated increased mortality Urinary tract infection UTIs significantly frequent survivor p0001 shift combination therapy monotherapy particularly ceftazidimeavibactam CZA observed aligning international guidelines Patients receive adequate antibiotic treatment significantly higher mortality OR636 p0001 Monotherapy aminoglycosides ceftazidimeavibactam tigecycline cotrimoxazole SXT fluoroquinolones common survivors Conversely combination therapy involving highdose meropenem HDMEM aminoglycosides common among nonsurvivors Mortality exceptionally high 2019 2020 single explanatory factor identified Conclusion study finding highlight importance rigorous infection control measures optimization antimicrobial therapy continuous surveillance antimicrobial resistance growing reliance monotherapy underscore necessity antimicrobial stewardship program prevent development resistance Additional multicenter study needed optimize therapeutic strategy improve patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40342464/",
        "source_type": "Global"
    },
    {
        "pmid": "40331021",
        "title": "Prevalence and antimicrobial resistance of gram-positive pathogens in Lebanon: The need for surveillance and stewardship.",
        "abstract": "Resistance Grampositive organisms including methicillinresistant iStaphylococcus aureusi MRSA vancomycinresistant iEnterococcusi VRE pose significant healthcare challenge globally However data organism Lebanon remain limited retrospective study aimed assess prevalence antimicrobial resistance pattern iStaphylococcus aureusi iS aureusi coagulasenegative iStaphylococcii CoNS iEnterococcusi spp clinical infection Lebanese Hospital Geitaoui  UMC 2017 2023 total 2676 isolates collected urine blood respiratory specimens infection sites Bacterial identification performed following clinical bacteriology procedures utilizing gram staining catalase coagulase tests biochemical assays Antimicrobial susceptibility testing conducted using KirbyBauer disk diffusion method minimum inhibitory concentration MIC analysis interpreted according Clinical Laboratory Standards Institute CLSI guidelines Statistical analysis performed using SPSS® version 24 significance set p  005 CoNS prevalent 4283  followed iEnterococcusi spp 2881  iS aureusi 2836  Blood culture highest isolation rate 2904  predominantly CoNS 7645  iEnterococcusi spp dominated urinary tract infection 8501  iS aureusi prevalent woundsurgical site infection 5923  Genderspecific trend showed CoNS iS aureusi males iEnterococcusi spp infection common females study provides valuable insight prevalence resistance pattern Grampositive pathogen Lebanese hospital setting finding highlight need continuous surveillance stringent antibiotic stewardship combat antimicrobial resistance effectively",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40331021/",
        "source_type": "Global"
    },
    {
        "pmid": "40328641",
        "title": "Identifying context-specific determinants to inform improvement of antimicrobial stewardship implementation in healthcare facilities in Asia: results from a scoping review and web-based survey among local experts.",
        "abstract": "International guideline available assessment improvement antimicrobial stewardship AMS programmes important strategy address escalating global antimicrobial resistance problem However existing AMS assessment tool lack contextual specificity resourcelimited settings leading limited applicability Asia project aimed identify relevant theme current guidance document help develop contextspecific assessment tool applied healthcare facility HCFs improve local implementationWe performed sequential approach scoping review identify relevant assessment theme Asia expert survey getting feedback relevance assessment stem developed scoping review reviewed Englishlanguage published document discussing AMS implementation assessment HCFs globally Asia Themes derived content analysis classified following predefined context dimension develop assessment stems defined containing one identified determinant may influence implementation outcomes survey consisting identified assessment stem reviewed 20 locally identified expert Asia rated level relevance stem AMS implementation regionNational leadership training technical support policy guidance commonly identified theme among 100 theme identified 73 reviewed documents themes developed 131 assessment stem expert survey 131 assessment stems 117 89 considered relevant AMS implementation Asia least 80 respondents stem included process developing global AMS assessment tool support HCFs improve programmesIn conclusion national leadership support represent distinct important aspect affecting AMS implementation HCFs Asia identified assessment theme substantial value formulation locally relevant implementation strategy tailored Asian context",
        "mesh_terms": [
            "Humans",
            "Health Facilities",
            "Asia",
            "Surveys and Questionnaires",
            "Antimicrobial Stewardship",
            "Quality Improvement"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40328641/",
        "source_type": "Global"
    },
    {
        "pmid": "40316407",
        "title": "Correct diagnostic classification and treatment of pneumonia symptoms in under-five children, northwest Ethiopia: a cross-sectional study.",
        "abstract": "Despite Ethiopias adoption Integrated Management Newborn Childhood Illnesses IMNCI strategy pneumonia continues leading infectious cause death among underfive children Therefore study aimed determine proportion underfive child received accurate diagnostic classification appropriate treatment symptom pneumonia using IMNCI guideline identify factor associated guideline adherence crosssectional study conducted March July 2023 among sick underfive child visited health centre South Gondar zone northwest Ethiopia employed twostage random sampling Observation healthcare providers clinical assessment diagnosis treatment reassessing children interviewing caregiver healthcare providers facility audit applied collect data descriptive multilevel binary logistic regression analysis done 356 95 CI 332 380 sick child pneumonia symptom received correct classification treatment Factors associated accurate diagnostic classification appropriate treatment included young infant adjusted AOR 28 95 CI 14 54 absence fever AOR 15 95 CI 11 20 longer consultation time AOR 14 95 CI 11 19 receiving care healthcare provider referred chart booklet diagnosis treatment AOR 39 95 CI 28 54 taking IMNCI training AOR 24 95 CI 15 37 lower patient caseloads AOR 17 95 CI 11 26 regular review meeting health service quality AOR 18 95 CI 13 25 proportion correct classification treatment sick child pneumonia symptom low leading poor treatment outcomes irrational use antibiotic antimicrobial resistance Almost clusterlevel associated factor modifiable Strengthening accountability mentoring implementing tailored strategy crucial enhancing healthcare providers adherence IMNCI guidelines",
        "mesh_terms": [
            "Humans",
            "Ethiopia",
            "Cross-Sectional Studies",
            "Pneumonia",
            "Male",
            "Female",
            "Child, Preschool",
            "Infant",
            "Guideline Adherence",
            "Infant, Newborn"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40316407/",
        "source_type": "Global"
    },
    {
        "pmid": "40306484",
        "title": "Reevaluating Surgical Antibiotic Prophylaxis in Pediatric Pyloromyotomy: Insights From the NSQIP-Pediatric Database.",
        "abstract": "Pyloromyotomy clean surgical procedure low risk surgical site infection SSIs Despite this surgical antibiotic prophylaxis SAP often administered raising concern unnecessary antibiotic exposure antimicrobial resistance study aim evaluate whether SAP reduces SSI rate infant undergoing pyloromyotomy hypertrophic pyloric stenosis propose guideline selective SAP omission retrospective cohort study analyzed data National Surgical Quality Improvement ProgramPediatric database Infants undergoing pyloromyotomy January 1 2021 December 31 2023 included primary outcome occurrence SSIs within 30 day postoperatively Secondary outcome included stratified rate superficial deep incisional organspace SSIs Among 4917 infant age 1 year 8426  male 4948  received SAP Additionally 81 patient 165  received postoperative antibiotic beyond intraoperative period overall SSI rate 142  primarily comprised superficial SSIs significant difference SSI rate infant receiving SAP 115  receiving SAP 169  p  0110 rate unplanned readmission unplanned return operating room within 30 day 244  104  respectively significant difference received postoperative antibiotic p  02 comparisons Routine SAP administration pyloromyotomy unnecessary given low risk SSIs SAP ASA Class II infant undergoing isolated pyloromyotomy without mucosal perforation immunecompromising conditions infections trauma omitted finding support effort optimize antibiotic stewardship pediatric surgical practice Original Research Article III",
        "mesh_terms": [
            "Humans",
            "Antibiotic Prophylaxis",
            "Retrospective Studies",
            "Infant",
            "Surgical Wound Infection",
            "Male",
            "Female",
            "Pyloric Stenosis, Hypertrophic",
            "Pyloromyotomy",
            "Databases, Factual",
            "Infant, Newborn",
            "Quality Improvement",
            "Anti-Bacterial Agents",
            "Practice Guidelines as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40306484/",
        "source_type": "Global"
    },
    {
        "pmid": "40301735",
        "title": "Epidemiology of clinical antimicrobial-resistant Enterobacterales in Togo over three decades: a systematic review and meta-analysis, with recommendations and alternative solutions.",
        "abstract": "According World Health Organization WHO surveillance program become essential national regional global level adjust empirical treatment target intervention prevent control emergence antimicrobial resistance AMR Therefore study aimed conduct first systematic review metaanalysis clinical Enterobacterales resistance 11 representative antimicrobial AWaRe Access Watch Reserve list provide recommendation tackle AMR efficiently Togo Preferred Reporting Items Systematic Reviews MetaAnalyses guideline The PRISMA 2020 used conduct study protocol registered PROSPERO CRD42024606897 Keywords used conduct systematic literature review electronic databases Data analysis conducted using Stata software version 170 Twenty research article reporting 9327 clinical Enterobacterales isolates obtained 1991 2020 included review mainly Escherichia coli 6639 712 Klebsiella spp 2542 273 mainly isolated urine 14 studies 70 puswounds 12 60 pooled Enterobacterales resistance rate ranged 1 95 CI 0 2 imipenem 3 95 CI 1 5 amikacin 4 95 CI 2 7 fosfomycin 50 95 CI 40 60 chloramphenicol 55 95 CI 45 64 gentamicin 68 95 CI 59 76 ciprofloxacin 73 95 CI 66 80 amoxicillinclavulanic acid AMC 79 95 CI 71 86 thirdgeneration cephalosporin 3GC 90 95 CI 86 93 sulfamethoxazoletrimethoprim SXT significant upward trend 30 year reported SXT Rsup2sup  7324 p  0001 ciprofloxacin Rsup2sup  6144 p  0001 3GC Rsup2sup  1849 p  0001 Klebsiella spp strain significantly resistant chloramphenicol p  003 E coli isolates whereas E coli isolates significantly resistant amikacin p  004 Klebsiella spp isolates study revealed high firstline AMR rate drastic upward trend clinical Enterobacterales isolated Togo past 30 years Thus adjustment empirical antimicrobial treatment Togo becomes crucial Moreover implementation prevention policies wholegenome sequencing approaches promotion antibiotic stewardship must enhanced Finally alternative therapeutic approaches phytotherapy phage therapy discussed applicable",
        "mesh_terms": [
            "Humans",
            "Togo",
            "Anti-Bacterial Agents",
            "Enterobacteriaceae Infections",
            "Enterobacteriaceae",
            "Drug Resistance, Bacterial",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40301735/",
        "source_type": "Global"
    },
    {
        "pmid": "40291400",
        "title": "Clinical presentation, diagnostics, and outcomes of infants with congenital and postnatal tuberculosis: a multicentre cohort study of the Paediatric Tuberculosis Network European Trials Group (ptbnet).",
        "abstract": "According estimates globally 200000 pregnant woman develop tuberculosis TB annually Despite this data perinatal TB remain scarce study aimed describe perinatal TB comprising congenital cTB postnatal pTB TB European setting Retrospective cohort study via Paediatric Tuberculosis Network European Trials Group ptbnet capturing comparing case cTB pTB diagnosed 104 participating European healthcare institution 1995 2019 Fortysix case reported 20 centre included final analysis cTB n  27 pTB n  19 Median age symptom onset one week cTB IQR 01 weeks 12 week pTB patient IQR 518 weeks Prematurity common cTB pTB patient 579 1119 95 CI 363769 vs 211 419 95 CI 85433 p  0049 average birth weight significantly lower 1680 g IQR 9322805 g vs 2890 g IQR 24613400 g p  00043 Microbiological confirmation achieved patient 852 2327 95 CI 675941 vs 789 1519 95 CI 567915 p  070 sensitivity interferongamma release assay poor group 250 312 95 CI 89532 vs 357 514 95 CI 163612 p  068 contrast sensitivity tuberculin skin test at 5 mm cutoff significantly higher pTB patient 167 212 95 CI 47448 vs 667 1015 95 CI 417848 p  00185 Approximately half patient required intensive care support 519 1427 95 CI 340693 vs 474 919 95 CI 273683 p  099 Four 446 87 patient died four 446 87 severe longterm sequelae substantial mortality morbidity patient cohort despite highresource setting cTB associated premature birth low birth weight contrast microbiological tests immunological test perform poorly perinatal TB therefore used ruleout tests studyspecific funding",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40291400/",
        "source_type": "Global"
    },
    {
        "pmid": "40277387",
        "title": "Nature of antimicrobial resistance of pathogens causing urinary tract infection in Bangladesh: age and gender profiles.",
        "abstract": "years clinical management urinary tract infection UTIs continuously evolving challenge resistance antibiotics addition investigating nature antimicrobial resistance antibiotics study investigate age gender nature patient resistances Patients prescribed urine culture sensitivity test part treatment tertiarylevel hospital Dhaka Bangladesh included sample Urine culture done following guideline CLSI sensitivity test done following KirbyBauer sensitivity method 55 male female found infected iEscherichia colii 15 infected iKlebsiellai pathogen detected iEnterococcusi iCandidai Age gender nature iE colii indicates female infected age 60 years male infected age iE colii exhibited least resistance Azithromycin Netilmicin Amikacin resistance Ciprofloxacin show female resistant age 60 years male that Multidrug resistance show alarming result 20 infected patient resistant nine antibiotics study clearly indicates UTI continuously evolving problem investigation remain continuous process economic social practice Bangladesh urinary tract infection continually evolving disease treatment requires relatively updated information behavior pathogen causing infection sufficient information Bangladesh age gender nature infected patients infected pathogens antibiotic resistance Moreover indiscriminate uncontrolled use antibiotic within country nature multidrug resistance pathogen also important effective management patients research attempt address issues",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Urinary Tract Infections",
            "Male",
            "Female",
            "Middle Aged",
            "Adult",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests",
            "Young Adult",
            "Aged",
            "Adolescent",
            "Escherichia coli",
            "Age Factors",
            "Drug Resistance, Bacterial",
            "Sex Factors",
            "Drug Resistance, Multiple, Bacterial",
            "Bacteria",
            "Child",
            "Child, Preschool",
            "Candida",
            "Klebsiella",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40277387/",
        "source_type": "Global"
    },
    {
        "pmid": "40263135",
        "title": "SAGES white paper on antibiotic omission in the management of acute uncomplicated diverticulitis: why, when, who, and most importantly, how.",
        "abstract": "Historically management acute uncomplicated diverticulitis centered antibiotics However modern theory regarding pathogenesis diverticulitis challenged notion antibiotic necessary cases Despite major reform many societal guidelines adoption nonantibiotic therapy uncomplicated diverticulitis limited especially North America purpose SAGES White Paper review available evidence antibiotic omission uncomplicated diverticulitis explore method safe implementation task force within SAGES Colorectal Surgery Committee formed work White Paper committee leadership approved outline would focus following topics 1 Defining problem unnecessary antibiotic exposure 2 Evaluating evidence antibiotic omission uncomplicated diverticulitis 3 Identifying appropriate patient antibiotic omission 4 Outlining counsel patient treated without antibiotics 5 Reviewing method safely implement practice hospital community setting topic divided among member task force performed structured literature search preparation assignments Antibiotics associated several patient societal adverse effects including rising problem antimicrobial resistance Randomized controlled trial demonstrated superiority routine administration antibiotic acute uncomplicated diverticulitis Appropriate patient antibiotic omission include immunocompetent nonseptic mild symptomsdisease severity imaging Existing framework safe implementation new practice referenced help increase adoption nonantibiotic therapy existing body evidence support antibiotic omission appropriate case acute uncomplicated diverticulitis order increase widespread adoption practice buyin key stakeholder both healthcare professional patients necessary",
        "mesh_terms": [
            "Humans",
            "Anti-Bacterial Agents",
            "Diverticulitis, Colonic",
            "Acute Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40263135/",
        "source_type": "Global"
    },
    {
        "pmid": "40251549",
        "title": "A retrospective clinical evaluation of the quality of antibiotic use in treating ear, nose and throat infections in ambulatory care setting of a teaching hospital in Ghana: findings and implications.",
        "abstract": "Ear nose throat ENT infection often associated high level morbidity mortality Antibiotic overuse misuse ENT infection reported caused lack expertise uncertainty distinguish infection types study sought determine level appropriateness antibiotic ENT infection associated factor ambulatory care teaching hospital Ghana guide future policy given rising resistance rates retrospective crosssectional study design undertaken audit quality antibiotic use Ho Teaching Hospital leading teaching hospital Ghana January 2022 December 2022 checklist designed extract patient sociodemographic clinical information electronic medical records main study outcome appropriate choice antibiotic principally accordance Ghana standard treatment guidelines Descriptive bivariate multivariate analysis performed data collected using STATA version 14 electronic medical record total 3279 patient extracted majority 5788 n  1898 patient females median interquartile range age 25 742 years Ear infection commonest 6624 n  2172 diagnosed ENT infection followed throat infection 1574 n  516 prescribed antibiotic oral amoxicillinclavulanic acid together topical neomycinsteroid combination 2800 n  918 followed amoxicillinclavulanic acid alone 1869 n  613 appropriate choice antibiotic ENT infection accordance treatment guideline 6011 Inappropriate use antibiotic high one antibiotic World Health Organisation WHO Watch group antibiotic prescribed ear infection compared nose throat infection treated appropriateness antibiotic use ENT infection hospital suboptimal predicted type infection number antibiotic prescribed AWaRe group Antimicrobial stewardship intervention clinical audit feedback clinician education must enhanced among thing identify antibiotic use gap help reduce unnecessary use antibiotic ENT infections",
        "mesh_terms": [
            "Humans",
            "Ghana",
            "Female",
            "Anti-Bacterial Agents",
            "Retrospective Studies",
            "Male",
            "Adult",
            "Hospitals, Teaching",
            "Cross-Sectional Studies",
            "Young Adult",
            "Adolescent",
            "Child",
            "Ambulatory Care",
            "Pharyngitis",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40251549/",
        "source_type": "Global"
    },
    {
        "pmid": "40251544",
        "title": "Carbapenem De-escalation in urinary tract infections: prevalence and outcomes among hospitalized patients.",
        "abstract": "evaluate prevalence outcome carbapenem deescalation among hospitalized urinary tract infection UTI patient Jordan University Hospital January 2022 March 2024 retrospective study included adult patient received carbapenems empirical therapy underwent urine culture testing Patients discharged culture result n  31 excluded primary outcome assess rate effective deescalation transition narrowerspectrum antibiotic without therapeutic failure Secondary outcome included effect successful deescalation patients hospital length stay relationship urine culture result success deescalation determining whether deescalate factor clinical stability urine culture result susceptibility considered Chisquare test assessed association culture result deescalation success total 205 patient received carbapenems empirical therapy underwent urine culture testing included study these 116 individual 566 negative culture results indicating infection 89 individual 434 tested positive confirming presence infection Among patients 956 196 205 required deescalation treatment whereas 44 not prevalence successful deescalation 403 79 196 analysis revealed successful deescalation much likely case urine culture showing growth 868 compared growth 172 p  0001 study also indicated significant difference length hospital stay successfully deescalated group failed incorrectly deescalated P  005 study underscore challenge implementing effective antibiotic stewardship UTI management particularly regarding carbapenem deescalation Enhanced protocol clinician education essential optimize deescalation practices especially case negative microbiological results research needed refine strategy address growing issue antibiotic resistance UTIs",
        "mesh_terms": [
            "Humans",
            "Urinary Tract Infections",
            "Carbapenems",
            "Retrospective Studies",
            "Male",
            "Female",
            "Middle Aged",
            "Anti-Bacterial Agents",
            "Prevalence",
            "Aged",
            "Adult",
            "Jordan",
            "Hospitalization",
            "Treatment Outcome",
            "Length of Stay",
            "Aged, 80 and over",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40251544/",
        "source_type": "Global"
    },
    {
        "pmid": "40250196",
        "title": "Selective decontamination of the digestive tract in burn patients: A systematic review with meta-analysis.",
        "abstract": "mechanically ventilated adult patient intensive care unit ICU selective decontamination digestive tract SDD shown reduce risk infection improve survival benefit SDD documented population remains unclear whether burn patients increased risk infection distinct clinical characteristics may experience similar benefits systematic review aimed assess desirable undesirable patientimportant effect administering SDD burn patients conducted systematic review metaanalysis randomized clinical trial RCTs assessing effect SDD versus placebo SDD burn patients primary outcome 30day mortality Secondary outcome included serious adverse events antimicrobial resistance pneumonia blood stream infections ICU hospitalfree days 90day mortality searched major database followed recommendation provided Cochrane Collaboration Preferred Reporting Items Systematic Reviews MetaAnalyses guidelines certainty evidence assessed according Grading Recommendations Assessment Development Evaluation approach identified four RCTs total 457 burn patients trial assessed either some concerns high risk bias evidence found uncertain across outcome assessed mortality relative risk RR 062 95  confidence interval CI 022178 Isup2sup  75  randomeffects model REM low certainty evidence pneumonia RR 075 95  CI 048119 Isup2sup  0  fixedeffect model low certainty evidence bloodstream infections RR 110 95  CI 071169 Isup2sup  0  REM low certainty evidence hospital length stay mean difference 203 day 95  CI 964559 Isup2sup  51  REM low certainty evidence perform metaanalyses remaining secondary outcome due limited data Trial sequential analysis could performed due insufficient number total participant event included trials found certainty evidence low effect SDD patientimportant outcome burn patients Extrapolating evidence mechanically ventilated adult ICU patient may reasonable data RCTs burn patient emerge",
        "mesh_terms": [
            "Humans",
            "Burns",
            "Decontamination",
            "Gastrointestinal Tract",
            "Respiration, Artificial",
            "Intensive Care Units",
            "Randomized Controlled Trials as Topic",
            "Anti-Bacterial Agents",
            "Bacteremia",
            "Pneumonia",
            "Length of Stay"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40250196/",
        "source_type": "Global"
    },
    {
        "pmid": "40238794",
        "title": "A qualitative study on factors influencing health workers' uptake of a pilot surgical antibiotic prophylaxis stewardship programme in selected Georgian hospitals.",
        "abstract": "Antimicrobial misuse surgical antibiotic prophylaxis SAP include inappropriate use broadspectrum antibiotic prolonged dosing 2021 pilot antimicrobial stewardship programme ASP launched Georgia involved developing adapting SAP guidelines establishing interprofessional SAP prescribing approach collecting surgical site infection SSI data via routinely collected data telephonic patient followups providing surgical unit staff prescribing feedback training antimicrobial resistance AMR antimicrobial stewardship AMS ASP introduction staggered across ten hospital three years study explored behavioural determinant surgical teams ASP uptake five hospital ASP introduced introduced Findings primarily concerned epidemiologists nurses ASPrelated behaviour ASP nonintroduced hospital less involved SAP prescribing process lower AMR awareness lacked professional development opportunities ASPintroduced hospital exhibited higher AMR knowledge felt ASP participation boosted confidence facilitated work furnished key professional development Results indicate interprofessional collaboration SAP prescribing supported ASP uptake across teams investment health worker training administrative encouragement ensured effective ASP participation implementation Findings highlight crucial role epidemiologist SAP illustrate need developing Georgian nurses AMR competency vehicle address public AMR knowledge gaps Longerterm ASP uptake need consider regulatory context hospital lack access nationallevel SSI data feedback SSI reporting fined reporting noncompliance Despite resource limitation small sample size study engaged pilot ASP health workers Respondents inexperience qualitative research participation ensuant hesitation limited exploration motivational factor supporting health workers ASP uptake could explored research",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40238794/",
        "source_type": "Global"
    },
    {
        "pmid": "40221805",
        "title": "Clarithromycin-resistant Helicobacter pylori in Africa: a systematic review and meta-analysis.",
        "abstract": "2022 approximately 565 adult 471 child adolescent affected Helicobacter pylorus H pylori infection Africa clarithromycinresistant H pylorus CRHp strain become global priority pathogens Therefore study aimed conduct first comprehensive systematic review metaanalysis CRHp Africa investigation conducted according guideline Preferred Reporting Items Systematic review MetaAnalyses The PRISMA 2020 Literature search electronic database Google Scholar African Journals Online ResearchGate PubMed Embase Scopus performed using keywords clarithromycin Helicobacter pylori African country name mutation 23S rRNA Sixtyfive study involving 5313 H pylorus strain isolated 26 year 19972022 23 African country included study sample CRHp isolated included gastric biopsy 6063 95 stool 463 6 pooled prevalence CRHp Africa 27 95 CI 22 33 steady trend prevalence CRHp isolated Africa 26 year Rsup2sup  00001 p  092 slope coefficient 005x Ten type 23S rRNA mutation conferring clarithromycin resistance identified included mainly A2143G 465 H pylorus strain 1178 tested A2142G 344 H pylorus strain 1027 enhance accuracy validity surveillance data H pylorus Africa urgent need implementing standardized microbiological method resistance detection prevalence CRHp reported study similar overall global prevalence need representative study CRHp Africa waiting this treatment H pylorus infection must based guideline AHMSG first Lagos consensus",
        "mesh_terms": [
            "Humans",
            "Africa",
            "Anti-Bacterial Agents",
            "Clarithromycin",
            "Drug Resistance, Bacterial",
            "Helicobacter Infections",
            "Helicobacter pylori",
            "Prevalence",
            "RNA, Ribosomal, 23S"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40221805/",
        "source_type": "Global"
    },
    {
        "pmid": "40217863",
        "title": "Antibiotic Use Patterns at Jimma Medical Center in Southwest Ethiopia: A Call for Local Antibiogram-Guided Prescription.",
        "abstract": "bBackgroundb discovery antibiotic revolutionized healthcare significantly reducing morbidity mortality However excessive inappropriate use led global surge antimicrobial resistance particularly low middleincome countries study aimed evaluate antibiotic use pattern among inpatient Jimma Medical Center JMC Southwest Ethiopia bMethodsb longitudinal observational study conducted February March 2019 JMC focusing patient admitted 24 h received antibiotics Data patient demographics clinical indications antibiotic prescribed systematically collected Antibiotic consumption rate measured day therapy DOTs per 100 patientdays utilization classified according World Health Organization WHO AWaRe Access Watch Reserve framework bResultsb total 384 inpatient included male predominance 539 median age 24 year IQR 537 total 634 antibiotic regimen prescribed According AWaRe classification 483 306634 Access 517 328634 Watch antibiotics Patients treated antibiotic median duration 4 day IQR 27 leading total 2880 day antibiotic therapy Ceftriaxone commonly prescribed antibiotic usage rate 4465 DOTs per 100 patientdays Substantial variability observed empirical antibiotic regimen among treating physician across wards Culture antibiotic susceptibility testing AST performed 42 patients none treatment modified based susceptibility data bConclusionsb study highlight critical issue antibiotic prescribing JMC including overreliance Watch antibiotics predominantly ceftriaxone limited use AST results deviation standard treatment guidelines Addressing challenge requires implementing antimicrobial stewardship programs developing evidencebased local treatment guidelines strengthening encouraging use microbiology service improve rational antibiotic use",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40217863/",
        "source_type": "Global"
    },
    {
        "pmid": "40217166",
        "title": "Prevalence, antibiogram, and risk factors of methicillin-resistant Staphylococcus aureus (MRSA) asymptomatic carriage in Africa: a systematic review and meta-analysis.",
        "abstract": "MRSA represents significant public health challenge particularly resourceconstrained region like Africa critical factor spread role asymptomatic carriers facilitate transmission also face markedly higher risk developing MRSArelated infections backdrop current metaanalysis provides comprehensive evaluation MRSA colonization rates associated risk factors antibiotic resistance profile across African populations comprehensive literature search conducted across African Journals Online African Index Medicus PubMed Scopus Google Scholar Web Science January 1 2014 January 1 2025 Eligible study reported MRSA colonization rates associated risk factors antibiotic resistance pattern within African populations Results presented pooled prevalence risk ratio RR 95 confidence intervals employing randomeffects model R software meta package pvalue  005 considered statistically significant study followed PRISMA guideline throughout Sixtynine study 23484 participant 16 African country included Subgroup analysis identified Healthcare Workers hospitalized patient highest pooled prevalence 136 129 respectively Conversely lower prevalence rate observed among healthy community resident children 41 47 respectively Among HCWs Egypt reported highest MRSA colonization rate 181 Key risk factor MRSA colonization include history hospitalization RR 22 prior antibiotic use RR 14 diabetes mellitus RR 44 HIV CD4  200 cellsµL RR 28 invasive procedure RR 48 nurse compared physician RR 18 p  005 Antibiotic resistance MRSA low linezolid 27 vancomycin 59 higher mupirocin 107 clindamycin 236 Trimethoprimsulfamethoxazole 389 MRSA colonization significant public health challenge Africa particularly among healthcare worker hospitalized patients Implementing targeted intervention highrisk group effectively reduce MRSA transmission overall infection burden Continuous monitoring essential especially given resistance mupirocin key antibiotic used MRSA decolonization",
        "mesh_terms": [
            "Humans",
            "Methicillin-Resistant Staphylococcus aureus",
            "Risk Factors",
            "Staphylococcal Infections",
            "Prevalence",
            "Carrier State",
            "Africa",
            "Anti-Bacterial Agents",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40217166/",
        "source_type": "Global"
    },
    {
        "pmid": "40200154",
        "title": "In silico genomic insights into bacteriophages infecting ESBL-producing Escherichia coli from human, animal, and environmental sources.",
        "abstract": "emergence antimicrobial resistance AMR Escherichia coli particularly extendedspectrum betalactamaseproducing E coli ESBLEC global public health concern Bacteriophages phages play significant role bacterial evolution spread antibiotic resistance gene ARGs study investigates prophages integrated within ESBLEC genome assess diversity gene content potential contribution ESBLEC persistence across human animal environmental reservoirs May December 2020 crosssectional study conducted Abuja Lagos collecting 448 stool cecal environmental sample abattoir workers slaughtered cattle abattoir environment ESBLEC genome samples obtained earlier study analyzed phage region using PHASTER Intact prophages analyzed silico using computational tool detect ARGs ESBL genes virulence factors heavy metal resistance genomic relationship examined statistical significance p  005 448 samples ESBLEC prevalence 217 97448 Among 97 ESBLEC isolates 646 prophage region detected 30 194646 classified intact phages Among 158 phage genus assignments Punavirus prevalent 601 Escherichia frequent predicted host 308646 particularly cattle n  143 human n  124 sources Among ESBLEC genomes 835 8197 intact phage carried phageassociated ARGs 763 7497 carried phageassociated ESBL genes 186 1897 harbored phageassociated virulence factors 155 1597 contained phageassociated plasmids 103 1097 heavy metal resistance prevalent phageassociated ARGs detected qnrS1 7381 blasubCTXM15sub 7281 Two isolates recovered abattoir worker carried two phagelike plasmids harboring either tetA blasubCTXM55sub gene predominant phage lifestyle temperate n  182 mainly Peduoviridae family lytic n  12 Punavirus genus first study Nigeria characterize phage ESBLEC isolates One Health interface presence intact phage humans animals environment underscore complex interaction shaping phage ecology discovery ARGs virulence genes heavy metal resistance within prophages suggests potential role AMR dissemination Future research focus elucidating mechanism ARG transfer mediated phage One Health settings",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Escherichia coli",
            "Cattle",
            "beta-Lactamases",
            "Cross-Sectional Studies",
            "Escherichia coli Infections",
            "Bacteriophages",
            "Feces",
            "Prophages",
            "Genomics",
            "Computer Simulation",
            "Genome, Viral",
            "Abattoirs"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40200154/",
        "source_type": "Global"
    },
    {
        "pmid": "40186221",
        "title": "National consumption of antimicrobials intended for use in animal livestock health: a retrospective data analysis of antimicrobial imports to Uganda from 2018 to 2020.",
        "abstract": "Antimicrobial use animal one major driver emergence spread resistant microorganisms Antimicrobial resistance AMR spread animal human vice versa However scanty data antimicrobial consumption livestock low middle income country especially Uganda Monitoring antimicrobial consumption use AMCU veterinary sector important identify area overuse misuse design targeted intervention reduce need unintentional exposure study aimed quantify characterize pharmacological class antimicrobial intended use animal different livestock production system imported annually Uganda extracted data Uganda National Drug Authority NDA database antimicrobial imported intended veterinary use 2018 2020 analysed quantity active pharmaceutical ingredient using World Organization Animal Health WOAH methodology reported consumption kilogram tonnes study period 2018 2020 210419 kg 150032 kg 142069 kg antimicrobial animal use imported country respectively annual average importation 167507 kg 1676 tons Antibacterials accounted 82 antiprotozoal accounted 18 total quantity three years Oxytetracycline top consumed antibacterial top five pharmacological class tetracycline 225 tons 448 aminogylcosides  penicillin combination 153 tons 297 sulfonamide trimethoprim 614 tons 124 macrolides 188 tons 39 fluoroquinolones 1676 tons 35 97 97 antibacterial Veterinary Critically Important Antimicrobials 571 Highly Important Antimicrobials group 321 Critically Important Antimicrobials group 107 Highest Priority group European Medicines Agency AMEG analysis revealed 571 lowest risk D category 365 intermediate risk C category 65 restricted use B category study provides baseline data nationallevel consumption antimicrobial used animal health different livestock production system Uganda future reference Annual quantification analysis veterinary AMCU continue inform monitoring distribution use relationship livestock population number burden diseases Antimicrobial stewardship pharmacovigilance activity animal health sector focus raising awareness adhering national international guidance appropriate prudent use antimicrobial agents",
        "mesh_terms": [
            "Animals",
            "Uganda",
            "Livestock",
            "Retrospective Studies",
            "Anti-Infective Agents",
            "Anti-Bacterial Agents",
            "Veterinary Drugs",
            "Drug Utilization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40186221/",
        "source_type": "Global"
    },
    {
        "pmid": "40180323",
        "title": "Antibiotics for common infections in primary care before, during and after the COVID-19 pandemic: cohort study of extent of prescribing based on risks of infection-related hospital admissions.",
        "abstract": "ObjectivesAntibiotics effective treating bacterial infections carry risk antimicrobial resistance effectiveness loss study aimed assess whether antibiotic common infection prescribed riskbased manner changed COVID19 pandemicDesignCohort study common infection antibiotic prescribingSettingWith approval NHS England accessed pseudonymised patientlevel electronic health record primary care data Phoenix Partnership OpenSAFELYParticipantsWe included adult registered general practice England record common infection including lower respiratory tract infection LRTI upper respiratory tract infection URTI lower urinary tract infection UTI January 2019 March 2023 Patients record COVID19 excludedMain outcome measuresPatientspecific risk infectionrelated hospital admission estimated infection using risk prediction score patient prescribed antibiotic infection cohort grouped risk deciles probability prescribed antibiotic assessedResultsWe found 15719750 diagnosis common infections them 450215 286 hospitalised 30 day diagnosis 10429060 6634 prescribed antibiotic substantial difference observed rate hospital admission lowest highest risk decile 25fold difference URTI probability prescribed antibiotic LRTI UTI unrelated hospital admission risk URTI weakly related hospital admission risk COVID19 pandemic level riskbased antibiotic prescribing reducedConclusionsThere need better target antibiotic primary care patient worse prognosis strengthen treatment guideline personalisation prescribing",
        "mesh_terms": [
            "Humans",
            "Anti-Bacterial Agents",
            "COVID-19",
            "Primary Health Care",
            "Male",
            "Female",
            "England",
            "Hospitalization",
            "Middle Aged",
            "SARS-CoV-2",
            "Aged",
            "Practice Patterns, Physicians'",
            "Adult",
            "Urinary Tract Infections",
            "Respiratory Tract Infections",
            "Cohort Studies",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40180323/",
        "source_type": "Global"
    },
    {
        "pmid": "40178717",
        "title": "Early appropriate therapy with polymyxin B reduces the mortality in burn sepsis caused by carbapenem-resistant gram-negative bacteria: a retrospective analysis.",
        "abstract": "prevalence CarbapenemResistant GramNegative Bacteria CRGNB rapidly escalating presenting significant global public health concern study aim evaluate survival rate early appropriate therapy polymyxin B PMB adverse drug reaction PMB treating severe burn sepsis caused CRGNB infections retrospectively analyzed 72 patient severe burn sepsis caused CRGNB infection January 1 2018 December 30 2023 patient received treatment regimen based PMB least three days collected data patients clinical characteristics microbiological results detail PMB treatment adverse drug reaction PMB mortality compared 30day mortality rate patient received early appropriate therapy the timely administration active antimicrobial agent within 48 h onset infection underwent nonearly appropriate therapy multivariate Cox regression analysis employed evaluate factor impacting 30day survival rate patients adverse drug reaction caused PMB also analyzed Among 72 patient severe burn sepsis clinical effective rate 694 5072 30day allcause mortality rate 319 2372 30day sepsisassociated mortality rate 278 2072 adverse drug reaction PMB included nephrotoxicity skin pigmentation incidence 194 1472 153 1172 respectively patient received early appropriate therapy lower mortality rate lower SOFA score wound infection compared underwent nonearly appropriate therapy all P  005 univariate Cox regression analysis showed age hypertension SOFA score time sepsis diagnosis early appropriate therapy PMB associated 30day allcause mortality sepsisassociated mortality severely burned patient all P  005 Additionally multivariate Cox regression analysis early appropriate therapy PMB identified independent protective factor 30day allcause mortality HR  0183 95 CI 00710468 P  0001 sepsisassociated mortality HR  0150 95 CI 00540414 P  0001 severely burned patients Polymyxin B effective option burn sepsis patient treating CRGNB infections Early appropriate therapy PMB significantly improved survival rate severe burn sepsis patient infected CRGNB",
        "mesh_terms": [
            "Humans",
            "Polymyxin B",
            "Retrospective Studies",
            "Male",
            "Burns",
            "Female",
            "Anti-Bacterial Agents",
            "Middle Aged",
            "Sepsis",
            "Gram-Negative Bacterial Infections",
            "Adult",
            "Gram-Negative Bacteria",
            "Aged",
            "Carbapenems",
            "Drug Resistance, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40178717/",
        "source_type": "Global"
    },
    {
        "pmid": "40176174",
        "title": "Reinvigorating AMR resilience: leveraging CRISPR-Cas technology potentials to combat the 2024 WHO bacterial priority pathogens for enhanced global health security-a systematic review.",
        "abstract": "Antimicrobial resistance AMR pose global health threat particularly low middleincome country LMICs Clustered regularly interspaced short palindromic repeat CRISPRCas system technology offer promising tool combat AMR targeting disabling resistance gene bacterial priority pathogens Thus systematically reviewed potential CRISPRCas technology address AMR systematic review adhered Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guidelines comprehensive literature search conducted using Scopus PubMed databases focusing publication 2014 June 2024 Keywords included CRISPRCas antimicrobial resistance pathogen eligibility criterion required original study involving CRISPRCas system targeted AMR Data extracted eligible studies qualitatively synthesized assessed bias using Joanna Briggs Institute JBIstandardized tool Data 48 eligible study revealed diverse CRISPRCas systems including CRISPRCas9 CRISPRCas12a CRISPRCas3 targeting various AMR genes blaOXA232 blaNDM blaCTXM ermB vanA mecA fosA3 blaKPC mcr1 responsible carbapenem cephalosporin methicillin macrolide vancomycin colistin fosfomycin resistance study explored role CRISPR virulence gene suppression including enterotoxin genes tsst1 iutA Staphylococcus aureus Klebsiella pneumoniae Delivery mechanism include bacteriophages nanoparticles electrotransformation conjugative plasmids demonstrate high efficiency vitro vivo CRISPRbased diagnostic application demonstrated high sensitivity specificity detection limit low 27 × 10sup2sup CFUmL significantly outperforming conventional methods Experimental study reported significant reduction resistant bacterial population complete suppression targeted strains Engineered phagemid particle plasmidcuring system shown eliminate IncF plasmids cured plasmid carrying vanA mcr1 blaNDM 94 efficiency restore antibiotic susceptibility Gene resensitization strategy used restore fosfomycin susceptibility E coli eliminate blaKPC2mediated carbapenem resistance MDR bacteria Wholegenome sequencing bioinformatics tool provided deeper insight CRISPRmediated defense mechanisms Optimization strategy significantly enhanced geneediting efficiencies offering promising approach tackling AMR highpriority pathogens CRISPRCas technology potential address AMR across priority pathogens promising challenge optimizing vivo delivery mitigating potential resistance navigating ethicalregulatory barrier must addressed facilitate clinical translation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40176174/",
        "source_type": "Global"
    },
    {
        "pmid": "40169989",
        "title": "Evaluation of the multiplex PCR combined with capillary electrophoresis technique for detecting pathogenic bacteria and antibiotic resistance genes in bone infections.",
        "abstract": "Orthopedic wound infection difficult problem clinic Accurate rapid microbiological test result essential case management antibiotic therapy infection control retrospectively evaluated 1285 specimen puncture fluid catheter secretions joint fluid lavage fluid extraction fluid blood culture drainage fluid cerebrospinal fluid bone prosthesis tissue etc 739 patient received orthopedic diagnosis treatment using routine conventional method RCMs reference method evaluate performance multiplex PCR combined capillary electrophoresis mPCRCE detecting pathogen antibiotic resistance gene associated bone infection Among 1285 sample analyzed 1045 sample consistent result RCM agreement rate 8132 Among 155 inconsistent results 13 101 mPCRCE negative RCM positive 142 1105 mPCRCE positive RCM negative Compared RCM mPCRCE demonstrated positive percentage negative percentage agreement value 6537 9835 respectively Moreover detection rate multidrugresistant bacteria mPCRCE method generally better RCM method detection rate methicillinresistant Staphylococcus aureus MRSA mPCRCE method relatively high traditional drugsensitive culture method inclined detect extendedspectrum βlactamases ESBLs mPCRCE method obvious advantage term timeliness study revealed mPCRCE new effective diagnostic method significantly reduce identification time bacterial identification drug resistance potential improve management orthopedic infections",
        "mesh_terms": [
            "Humans",
            "Multiplex Polymerase Chain Reaction",
            "Electrophoresis, Capillary",
            "Retrospective Studies",
            "Bacteria",
            "Middle Aged",
            "Male",
            "Female",
            "Adult",
            "Aged",
            "Anti-Bacterial Agents",
            "Drug Resistance, Bacterial",
            "Young Adult",
            "Aged, 80 and over",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40169989/",
        "source_type": "Global"
    },
    {
        "pmid": "40154881",
        "title": "A systematic review and meta-analysis on the efficacy of carbapenems versus metronidazole combination therapy in patients infected with Bacteroides spp.",
        "abstract": "Bacteroides spp frequently detected anaerobic infections mortality rate 50  attributed inadequate antimicrobial therapy Recently Bacteroides spp shown increased resistance metronidazole MNZ carbapenems Therefore identifying appropriate drug treating infection caused Bacteroides spp necessary Hence metaanalysis aimed compare clinical efficacy combination therapy MNZ versus carbapenems treatment infection due Bacteroides spp Scopus EMBASE PubMed CINAHL Ichushi database searched relevant article met inclusion criterion October 2024 Clinical efficacy defined percentage patient achieved complete resolution remarkable improvement sign symptom infection therefore additional antibiotic procedure necessary percentage eradication Bacteroides spp 482 citation identified screening five study total 306 patient enrolled included study randomized clinical trials two openlabel studies three doubleblind studies included patient intraabdominal infection IAIs combined therapy MNZ comparable carbapenem group clinical efficacy treatment infection due Bacteroides spp risk rate 103 95  confidence interval 093114 Combined therapy MNZ could effective treatment option infection caused Bacteroides spp similar carbapenems",
        "mesh_terms": [
            "Humans",
            "Metronidazole",
            "Carbapenems",
            "Anti-Bacterial Agents",
            "Bacteroides Infections",
            "Drug Therapy, Combination",
            "Bacteroides",
            "Treatment Outcome",
            "Randomized Controlled Trials as Topic",
            "Intraabdominal Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40154881/",
        "source_type": "Global"
    },
    {
        "pmid": "40151230",
        "title": "The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort study.",
        "abstract": "study aimed evaluate trend antimicrobial prescription first 15 year COVID19 pandemic observational retrospective cohort study using patientlevel data Bangladesh Brazil India Italy Malawi Nigeria South Korea Switzerland Turkey patient pneumonia andor acute respiratory distress syndrome andor sepsis regardless COVID19 positivity admitted critical care unit COVID19 specialized wards change antimicrobial prescription prepandemic pandemic estimated using logistic linear regression Pandemic effect monthwise antimicrobial usage evaluated using interrupted time series analysis ITSAs Antimicrobials prescription significantly increased pandemic follows meropenem Bangladesh 95 CI 194407 increased prescribed daily dose PDD 95 CI 117158 Turkey 95 CI 109158 moxifloxacin Bangladesh 95 CI 4111187 increased day therapy DOT 95 CI 114256 piperacillintazobactam Italy 95 CI 107148 increased DOT 95 CI 101125 PDD 95 CI 105121 azithromycin Bangladesh 95 CI 3362177 Brazil 95 CI 233842 ITSA showed significant drop azithromycin usage India 95 CI 838 349 g100 patients South Korea 95 CI 283 189 g100 patients guideline v1 release increased meropenem usage 95 CI 934012648 g100 patients moxifloxacin 95 CI 5401398 g100 patients Bangladesh sulfamethoxazoletrimethoprim India 95 CI 092932 g100 patients following Delta variant emergence study reinforces importance developing antimicrobial stewardship clinical setting interpandemic periods",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40151230/",
        "source_type": "Global"
    },
    {
        "pmid": "40149121",
        "title": "Antibiotic Usage for Treatment of Acute Upper Respiratory Tract Infections in Children in Lithuania from 2018 to 2022.",
        "abstract": "bBackgroundObjectivesb Acute upper respiratory tract infection URIs defined inflammatory disease nose sinuses pharynx larynx trachea common children prescription antibiotic treatment URIs became relevant theme scientific literature recent decades One important way deal increasing antimicrobial resistance rational antibiotic therapy study aimed evaluate tendency antibiotic prescribing practice Lithuanian child URIs 2018 2022 describe many child URIs prescribed antibiotics antibiotic used whether prescribing practice meet national guidelines bMethodsb Secondary data used observational study collected Lithuanian Compulsory Health Insurance Fund CHIF electronic records study population consisted child aged 0 18 year visited primary care doctor pediatricians family doctors January 2018 December 2022 prescribed antibiotic treatment URIs bResultsb 2018 2022 445328 visit reported antibiotics belong J01 group according Anatomical Therapeutic Chemical Classification ATC prescribed child aged 018 half visit 5170 child aged 05 consulted Penicillins mostly prescribed treatment acute nasopharyngitis Macrolides mostly used treat acute laryngitis tracheitis penicillinclass antibiotics popular choice amoxycillin primary choice cephalosporin cefadroxil primary choice macrolide clarithromycin bConclusionsb period 20182022 number prescription antibiotic URTIs decreased prescription penicillinclass antibiotic increased relative manner common diagnosis visit acute tonsillitis acute pharyngitis antibiotic prescription child 05 age group Lithuanias National Recommendations Rational Use Antibiotics implemented analyzed period prescribing tendency would meet them",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40149121/",
        "source_type": "Global"
    },
    {
        "pmid": "40149101",
        "title": "Antibiotic Resistance and Mortality in ICU Patients: A Retrospective Analysis of First Culture Growth Results.",
        "abstract": "study aimed analyze antibiotic resistance pattern microorganism isolated intensive care unit ICU patient evaluate impact mortality length ICU stay Given increasing prevalence multidrugresistant MDR pathogen critically ill patients understanding resistance profile crucial optimizing empirical antibiotic therapy improving patient outcomes retrospective study included 237 ICU patient admitted 1 July 2022 1 January 2024 initial culture growth result blood urine sample analyzed Microorganism identification performed using VITEK 2 Compact conventional bacteriological methods antibiotic susceptibility testing followed CLSI 2022 EUCAST 2022 guidelines total 237 ICU patient included study frequently isolated microorganism iEscherichia colii iE colii 443 iKlebsiella pneumoniaei iK pneumoniaei 350 iPseudomonas aeruginosai iP aeruginosai 253 iwith Acinetobacter baumanniii iA baumanniii 312 resistant pathogen Among Grampositive bacteria imethicillinresistant Staphylococcus aureusi iMRSAi 122 vancomycinresistant enterococci iVREi 215 frequently identified multidrugresistant MDR pathogens Regarding antimicrobial resistance carbapenem resistance highest iA baumanniii 55 followed iP aeruginosai 40 iK pneumoniaei 30 Additionally ESBLproducing iE colii 432 iK pneumoniaei 385 well carbapenemaseproducing iK pneumoniaei 186 iE colii 92 identified key resistance mechanism impacting clinical outcomes Patients MDR infection significantly longer ICU stay ipi  005 higher mortality rates KaplanMeier survival analysis revealed iA baumanniii infection associated highest mortality risk HR 46 ipi  0001 followed iMRSAi HR 35 ipi  0005 iP aeruginosai HR 28 ipi  001 Among laboratory biomarkers elevated procalcitonin ≥2 ngmL OR 28 ipi  0008 CRP ≥100 mgL OR 22 ipi  001 significantly associated ICU mortality Additionally patient remained ICU seven day 14fold increased risk mortality ipi  002 emphasizing impact prolonged hospitalization adverse outcomes MDR pathogens particularly iA baumanniii iMRSAi iP aeruginosai iK pneumoniaei associated longer ICU stay higher mortality rates Carbapenem cephalosporin fluoroquinolone aminoglycoside resistance significantly impact clinical outcomes emphasizing urgent need antimicrobial stewardship programs ESBL pAmpC carbapenemaseproducing iEnterobacteralesi worsen patient outcomes highlighting need early infection control strategy optimized empirical antibiotic selection Biomarkers procalcitonin CRP alongside clinical severity scores serve valuable prognostic tool ICU mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40149101/",
        "source_type": "Global"
    },
    {
        "pmid": "40147462",
        "title": "Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis.",
        "abstract": "past 5 years since publication initial review study provided additional data macrolide fluoroquinolone resistance Mycoplasma genitalium including data region previously lacking information aimed provide contemporary estimate macrolide fluoroquinolone resistance genitalium inform national regional global treatment guidelines update previous systematic review metaanalysis performed Jan 7 2019 update searched PubMed Embase MEDLINE Jan 1 2018 April 18 2023 published study reporting macrolide fluoroquinolone dualclass macrolide fluoroquinolone resistance genitalium Data combined previous metaanalysis examine resistance prevalence genitalium sample collected including 2021 Randomeffects metaanalyses used calculate summary estimate prevalence Subgroup analysis region four time period before 2012 201821 performed study registered PROSPERO number CRD42021273340 166 study 59 previous search period reporting data genitalium sample collected 2003 2017 107 updated search period reporting data genitalium sample collected 2005 2021 included 157 reporting macrolide resistance 41 countries 22 974 samples 89 reporting fluoroquinolone resistance 35 countries 14 165 samples 74 reporting dualclass resistance 34 countries 11 070 samples 201821 overall prevalence macrolide fluoroquinolone dualclass resistance 33·3 95 CI 27·239·7 13·3 10·017·0 6·5 4·09·4 respectively time slight although statistically significant decline macrolide resistance Western Pacific Americas increase macrolide resistance European region Fluoroquinolone resistance highest Western Pacific increased European nonNordic region ParC S83I common variant associated fluoroquinolone resistance increasing 0 95 CI 0·00010·30 2012 7·3 4·710·3 201821 psubtrendsub0·055 Macrolide fluoroquinolone resistance genitalium requires ongoing international surveillance use resistance assay optimal antibiotic stewardship novel treatment options Australian Research Council",
        "mesh_terms": [
            "Mycoplasma genitalium",
            "Macrolides",
            "Fluoroquinolones",
            "Humans",
            "Mycoplasma Infections",
            "Anti-Bacterial Agents",
            "Drug Resistance, Bacterial",
            "Prevalence",
            "Microbial Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40147462/",
        "source_type": "Global"
    },
    {
        "pmid": "40108748",
        "title": "Fighting the Antimicrobial Resistance Global Emergency: The Lifesaving Role of Dentistry.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40108748/",
        "source_type": "Global"
    },
    {
        "pmid": "40102910",
        "title": "Molecular and genetic features of a bla<sub>NDM-1</sub> and bla<sub>SHV-12</sub> coharboring hypermucoviscous Klebsiella pneumoniae of serotype K2 and ST65.",
        "abstract": "study aimed assess resistance phenotype virulence phenotype genetic characteristic blasubNDM1sub blasubSHV12sub coharboring ST65 K2 Klebsiella pneumoniae KP114 isolated General hospital Ningxia Medical University Antibiotic susceptibility test determined Vitek 2 Compact system Multilocus Sequence typing MLST antimicrobial resistance virulence gene examined PCR Sanger sequencing virulence KP114 evaluated string test macrophage phagocytosis assay serum resistance assay mouse infection model Wholegenome sequencing performed analysis genetic information presence blasubNDM1sub blasubSHV12sub gene KP114 confered resistance multiantibiotics hypervirulence KP114 demonstrated various vitro experiment vivo mouse infection model KP114 found harbor two distinct plasmids drugresistant plasmid pKP114NDM classified IncX3 type contained various transfer element including type IV coupling protein T4CP type IV secretion system T4SS virulence plasmid pKP114vir exhibited high sequence similarity pLVPK result conjugation experiment showed resistance virulence trait successfully transferred KP114 Escherichia coli EC600 J53 reported Carbapenemresistant hypervirulent Klebsiella pneumoniae CRhvKP strain ST65 K2 serotype carrying blasubNDM1sub blasubSHV12sub exhibited hypervirulence drug resistance potential transmission finding allows improved clinical surveillance control clone thereby holding considerable value clinical treatment",
        "mesh_terms": [
            "Klebsiella pneumoniae",
            "Animals",
            "Mice",
            "beta-Lactamases",
            "Klebsiella Infections",
            "Anti-Bacterial Agents",
            "Multilocus Sequence Typing",
            "Serogroup",
            "Microbial Sensitivity Tests",
            "Humans",
            "Plasmids",
            "Virulence",
            "Drug Resistance, Multiple, Bacterial",
            "Whole Genome Sequencing",
            "Female",
            "Virulence Factors",
            "Bacterial Proteins",
            "Disease Models, Animal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40102910/",
        "source_type": "Global"
    },
    {
        "pmid": "40100363",
        "title": "Esc peptides and derivatives potentiate the activity of CFTR with gating defects and display antipseudomonal activity in cystic fibrosis-like lung disease.",
        "abstract": "Cystic fibrosis CF rare disease caused mutation gene encoding CF transmembrane conductance regulator CFTR chloride channel important role airways Despite clinical efficacy present modulators restoring activity defective CFTR patient show persistent pulmonary infections mainly due Pseudomonas aeruginosa Recently reported unprecedented property antimicrobial peptide ie Esc peptides consists ability act potentiators CFTR carrying common mutation the loss phenylalanine 508 affecting protein folding trafficking gating work electrophysiology experiment computational studies capability peptide denovo designed analog demonstrated recover function mutated form CFTR severely affect channel gating G551D G1349D presumably due direct interaction peptide nucleotide binding domain NBDs CFTR followed novel local phenomenon consisting distancing residue located cytosolic side NBDs interface thus stabilizing open conformation pore cytosolic end promising peptide dual antimicrobial CFTR potentiator activity also shown display antipseudomonal activity condition mimicking CF pulmonary ion transport mucus obstruction higher efficacy clinically used colistin study assist development novel drug lung pathology CF dual CFTR potentiator large spectrum antibiotic activities",
        "mesh_terms": [
            "Cystic Fibrosis Transmembrane Conductance Regulator",
            "Humans",
            "Cystic Fibrosis",
            "Pseudomonas aeruginosa",
            "Ion Channel Gating",
            "Antimicrobial Peptides",
            "Pseudomonas Infections",
            "Mutation",
            "Anti-Bacterial Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40100363/",
        "source_type": "Global"
    },
    {
        "pmid": "40092020",
        "title": "Prolonged Fever in a Multidrug-Resistant Typhoid Fever Patient Despite Appropriate Antimicrobial Therapy: A Case Report.",
        "abstract": "Typhoid fever caused iSalmonella entericai serovar Typhi iS Typhii remains significant global health concern emergence multidrugresistant MDR iS Typhii strains including extendedspectrum betalactamase ESBL producers complicated treatment limiting effectiveness firstline secondline antibiotics present case 10yearold boy developed prolonged febrile illness traveling typhoidendemic region Initial treatment ceftriaxone proved ineffective due presence ESBLproducing iS Typhii necessitating change meropenem combined azithromycin Despite persistent fever patient showed clinical improvement day five became afebrile day 11 improvement inflammatory marker resolution bacteremia confirmed sterile blood culture day 12 case underscore challenge managing MDR typhoid fever highlight critical need maintain appropriate antibiotic regimens even context prolonged febrile responses Furthermore draw attention global spread MDR extensively drugresistant XDR iS Typhii often facilitated international travel emphasizing need vigilant resistance monitoring empiric treatment adjustments Effective antibiotic stewardship adherence evidencebased guidelines heightened clinical awareness essential address complex public health clinical challenge posed MDR XDR iS Typhii",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40092020/",
        "source_type": "Global"
    },
    {
        "pmid": "40089213",
        "title": "Antibiotic chemoprophylaxis for close contacts of invasive group A streptococcus in community settings: Evidence review.",
        "abstract": "Revised UK guideline management contact invasive group Streptococcus iGAS infection community setting published December 2022 present finding narrative review informed public health recommendation around provision antibiotic chemoprophylaxis detailed updated guidelines conducted literature review study reporting risk iGAS infection associated specific risk factors strong epidemiological evidence increased risk iGAS infection contact older individuals postpartum women neonate individual chickenpox infection evidence impact influenza coinfection injecting drug use homeless increasing risk iGAS infection less robust guideline made recommendation offer chemoprophylaxis close contact iGAS case aged ≥75 years pregnant ≥37 week gestation postpartum neonate recent history of current chickenpox infection Systematic data collection evaluating use chemoprophylaxis control measure recommended",
        "mesh_terms": [
            "Humans",
            "Streptococcal Infections",
            "Female",
            "Anti-Bacterial Agents",
            "Antibiotic Prophylaxis",
            "Streptococcus pyogenes",
            "Pregnancy",
            "Risk Factors",
            "Infant, Newborn",
            "United Kingdom",
            "Aged",
            "Community-Acquired Infections",
            "Male",
            "Practice Guidelines as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40089213/",
        "source_type": "Global"
    },
    {
        "pmid": "40073975",
        "title": "Progress and challenges in the implementation of antimicrobial stewardship programs in 50 hospitals in Mexico.",
        "abstract": "Antimicrobial stewardship program ASP aim improve quality medical prescribing contain antimicrobial resistance AMR little information implementation ASP hospital Mexico study aimed characterize ASP sample hospital Mexico identify facilitator barrier perceived implementation including COVID19 pandemic selfassessment electronic survey adapted CDC ASPs core elements considering ASP organization structure education guidelines interventions surveillance monitoring reporting processes survey addressed ASP team leader sample public private hospital carrying regular antimicrobial stewardship activity Mexico 2021 2022 Fifty hospital participated 32 64 public 18 36 private Fiftytwo percent hospital official ASP document 12 allocated protected time ASP professionals 34 annual plan hospital ASP committee 68 14 allocated funding intervention restrictive 68 61 hospital prepared cumulative antibiograms periodically 54 monitored antimicrobial consumption DDDDOT 44 monitored adherence guidelines 24 monitored implementation interventions main barrier identified work overload insufficient human resources hospital reconversion due COVID19 particularly public hospitals support hospital authority important facilitator diagnosis provides baseline strengthening ASP implementation countrys hospitals National institutional policy prioritize targeting ASP planning monitoring human resource allocation",
        "mesh_terms": [
            "Antimicrobial Stewardship",
            "Mexico",
            "Humans",
            "COVID-19",
            "Hospitals",
            "SARS-CoV-2",
            "Surveys and Questionnaires",
            "Anti-Bacterial Agents",
            "Hospitals, Private",
            "Hospitals, Public"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40073975/",
        "source_type": "Global"
    },
    {
        "pmid": "40063324",
        "title": "Rapid diagnosis of urinary tract infection with miniaturised point-of-care cultivation on a dipstick.",
        "abstract": "Urinary Tract InfectionAQ1 UTI affect 400 million people annually globally major reason empiric antibiotic prescription general practitioner GPs problem related microbiological UTI diagnosis current lack point care POC diagnostics addition remote settings including low middle income country LMIC hard service Compliance requirement posed Vitro Diagnostic Regulation IVDR adherence guideline defined professional user group mandatory pursue addition World Health Organisation WHO promotes optimization antimicrobial use adequate microbiological diagnostics cure UTI combat antimicrobial resistance AMR Miniaturised chromogenic bacterial cultivation including rapid antimicrobial susceptibility testing RAST POC successfully used diagnosis UTI Using small costeffective dipstick containing chromogenic cultivation media UTIcausing bacteria detected quantified identified good sensitivity specificity Access trustworthy easytouse costefficient diagnostic tool POC would offer timely result optimised antibiotic treatment improve UTI therapy prevent AMR",
        "mesh_terms": [
            "Humans",
            "Urinary Tract Infections",
            "Point-of-Care Systems",
            "Microbial Sensitivity Tests",
            "Sensitivity and Specificity",
            "Point-of-Care Testing",
            "Bacteria",
            "Anti-Bacterial Agents",
            "Bacteriological Techniques"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40063324/",
        "source_type": "Global"
    },
    {
        "pmid": "40061860",
        "title": "Threats across boundaries: the spread of ESBL-positive <i>Enterobacteriaceae</i> bacteria and its challenge to the \"one health\" concept.",
        "abstract": "iβilactam antibiotic essential medication treating human diseases spread extendedspectrum βlactamaseproducing iEnterobacteriaceaei ESBLPE exists globally multiple reservoir natural environment pose immense threat public health Plasmid incompatibility groups IncFIA IncI1 IncY IncFIB IncN IncFIC IncX4 IncBOKZ IncHI12 IncAC exist humans animals environment carrying iblai subCTXMsub iblai subTEMsub iblai subSHVsub genes ISiEcp1i upstream orf477 downstream iblai subCTXMsub genes well mobile genetic element MGEs ISi903i ISi26i involved capturing mobilizing antibioticresistant gene ARGs iblai subCTXM15sub gene common among discussed reservoirs environmental reservoir propagation mode ESBLPE increasing difficult control reason include limited bacterial adaptability horizontal gene transfer HGT mediated MGEs plasmids Conjugation pathway HGT almost uncontrollable MGEs plasmid Tni3i ISi1380i families IncI1 IncK IncN facilitating HGT iblai subCTXMsub genes review highlight need monitor trend antimicrobial resistance AMR natural environment Therefore policy antibiotic management plans training healthcare provider andor patients cautious use antibiotics need epidemiological networks pretravel consultations World Health Organization WHO infection control biosafety guidelines intervention measure considered desirable",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40061860/",
        "source_type": "Global"
    },
    {
        "pmid": "40036749",
        "title": "Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline Resistance in Neisseria gonorrhoeae and Colonization With Tetracycline-Resistant Staphylococcus aureus and Group A Streptococcus.",
        "abstract": "Doxycycline postexposure prophylaxis doxy PEP increasingly used among men sex men MSM impact antimicrobial resistance microbiome uncertain used Neisseria gonorrhoeae NG surveillance data King County Washington USA joinpoint regression investigate trend NGtetracycline resistance tetR 20172024 and among sexual health clinic SHC patients evaluated association NGtetR doxy PEP use evaluated nasopharyngeal colonization Staphylococcus aureus Group Streptococcus GAS 703 MSM SHC patients August 2023July 2024 Among 2312 MSM NG tetR stable 2017 quarter 1 Q1 2023 mean  27 thereafter rose 70 Q2 2024 P  0001 King County released doxy PEP guideline Q2 2023 NG highlevel HL tetR increased Q1 2021 Q2 2024 2 65 P  0001 Taking 3 dos doxy PEPmonth associated tetR HL tetR P ≤ 01 both though use doxy PEP associated tetR HL tetR S aureus colonization less common among doxy PEP user nonusers 27 v 36 P  02 colonization tetracyclineresistant S aureus GAS common among doxy PEP user nonusers 18 v 8 P  0001 9 v 4 P  008 respectively TetR NG rapidly increased 2021 2024 NG among King County MSM HL tetR Doxy PEP use associated colonization GAS tetracyclineresistant S aureus suggesting doxy PEP impact offtarget bacteria",
        "mesh_terms": [
            "Humans",
            "Male",
            "Doxycycline",
            "Neisseria gonorrhoeae",
            "Anti-Bacterial Agents",
            "Gonorrhea",
            "Adult",
            "Tetracycline Resistance",
            "Staphylococcus aureus",
            "Post-Exposure Prophylaxis",
            "Streptococcus pyogenes",
            "Staphylococcal Infections",
            "Young Adult",
            "Middle Aged",
            "Homosexuality, Male",
            "Streptococcal Infections",
            "Washington"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40036749/",
        "source_type": "Global"
    }
]